Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

CIRRHOSIS_BROAD

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints K11_ALCOLIV FIBROLIV SCLEROLIV FIBROSCLEROLIV CHIRHEP_NAS I9_HYPTENSPOR I9_VARICVEOES	5691
6. Filter based on genotype QC (FinnGen only)	5691

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF3

NAME	CIRRHOSIS_BROAD
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_ALCOLIV\|FIBROLIV\|SCLEROLIV\|FIBROSCLEROLIV\|CHIRHEP_NAS\|I9_HYPTENSPOR\|I9_VARICVEOES
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523 based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	82343	22329	58113
Only index persons	48746	14732	34014
Unadjusted period prevalence (%)
Whole population	1.37	0.64	1.62
Only index persons	1.07	0.54	1.30
Median age at first event (years)
Whole population	57.17	59.00	56.47
Only index persons	58.89	60.06	58.39

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5691	1784	3907
Unadjusted period prevalence (%)	1.37	0.61	1.72
Median age at first event (years)	60.55	59.46	61.05

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5015: Matched controls
50161

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.3

323.0

1493

3733

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

+∞

323.0

405

R18

ICD-10 Finland

Ascites

52.1

323.0

875

203

C03DA01

ATC

spironolactone; oral

10.5

323.0

1985

2940

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

7.1

323.0

1232

2211

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

1087.6

323.0

401

C03CA01

ATC

furosemide; systemic

4.1

323.0

2549

10131

K70.0

ICD-10 Finland

Alcoholic fatty liver

1448.9

323.0

742

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

4499.4

323.0

1848

A06AD11

ATC

lactulose; oral

4.6

323.0

1513

4265

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

+∞

323.0

1085

K70.1

ICD-10 Finland

Alcoholic hepatitis

1553.3

323.0

787

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

5.8

323.0

2882

9492

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

7252.9

323.0

1562

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

373.7

323.0

351

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

10.8

323.0

1439

1805

K70.4

ICD-10 Finland

Alcoholic hepatic failure

2481.6

323.0

473

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

28.6

323.0

523

203

K92.0

ICD-10 Finland

Haematemesis

13.3

322.3

589

497

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

15.3

316.8

543

394

C07AA05

ATC

propranolol; systemic

4.0

306.2

1481

4730

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.9

304.5

587

553

F10.25

ICD-10 Finland

Alcohol dependence continuous use

15.8

281.0

474

328

P15

ICPC

Chronic alcohol abuse

10.6

271.9

554

578

F10.20

ICD-10 Finland

Alcohol dependence currently independent

12.9

253.1

467

396

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

33.1

236.2

314

101

F10.24

ICD-10 Finland

Alcohol depence active use

15.9

219.0

368

249

D64.9

ICD-10 Finland

Anaemia, unspecified

4.0

216.2

991

2903

N07BB01

ATC

disulfiram; oral

6.2

214.9

624

1119

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

18.7

214.3

338

193

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

205.6

196

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.7

200.1

1779

8378

K72.9

ICD-10 Finland

Hepatic failure, unspecified

55.2

194.1

232

103

Kela drug reimbursment

Diabetes, insulin-treated

2.6

191.8

1954

9901

Z94.4

ICD-10 Finland

Liver transplant status

73.9

186.5

213

K92.1

ICD-10 Finland

Melaena

5.3

186.1

623

1317

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

9.8

184.6

390

427

JJC00

NOMESCO Finland

Allogenic transplantation of liver

140.2

177.6

189

A07AA11

ATC

rifaximin; oral

350.8

170.3

171

K76.9

ICD-10 Finland

Liver disease, unspecified

15.5

169.1

286

195

K76.7

ICD-10 Finland

Hepatorenal syndrome

429.1

167.6

167

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

13.4

162.9

293

231

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

12.0

162.2

308

273

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.6

159.1

321

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

10.5

158.8

322

325

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

12.8

156.2

287

237

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

153.4

1163

4826

A05AA02

ATC

ursodeoxycholic acid; oral

14.9

153.1

263

186

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

20.5

151.7

231

118

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.8

151.6

1204

5138

A10AE04

ATC

insulin glargine; parenteral

3.4

149.7

826

2746

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.9

146.5

523

1173

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

10.4

144.5

294

298

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

16.4

142.4

235

150

F10.09

ICD-10 Finland

Alcohol intoxication UNS

8.7

141.8

320

390

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

5.4

140.6

450

892

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

13.5

135.2

242

188

D97

ICPC

Liver disease NOS

32.3

133.5

178

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

130.8

125

N05BA02

ATC

chlordiazepoxide; systemic

6.7

129.5

350

559

N05CF01

ATC

zopiclone; oral

2.2

128.2

1887

10902

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

126.9

638

1954

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

28.3

126.9

175

N06AX11

ATC

mirtazapine; oral

2.2

125.5

1730

9684

N02AX02

ATC

tramadol; systemic, rectal

2.0

124.6

2439

15840

A10BA02

ATC

metformin; oral

2.2

124.4

1788

10185

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.8

123.4

580

1678

T90

ICPC

Diabetes non-insulin dependent

2.3

123.0

1521

8079

K72.1

ICD-10 Finland

Chronic hepatic failure

184.5

121.0

126

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

35.7

120.0

156

B18.2

ICD-10 Finland

Chronic viral hepatitis C

17.2

119.6

193

116

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

23.5

119.1

173

A02BC02

ATC

pantoprazole; systemic

2.0

118.4

3378

25255

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.2

116.6

1575

8668

N05BA04

ATC

oxazepam; oral

2.3

116.1

1381

7164

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.9

113.7

766

2889

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.1

113.2

379

786

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

15.3

113.1

191

129

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.5

113.0

427

1007

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

113.6

112.5

122

A98

ICPC

Health maint/preventive medicine

0.5

111.6

3599

42593

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

16.6

110.5

181

113

N05AH04

ATC

quetiapine; oral

2.6

109.6

941

4106

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.1

108.9

689

2486

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

6.7

108.5

289

451

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

8.7

107.2

240

287

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

13.4

104.8

187

144

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

12.1

104.6

196

168

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

8.0

103.9

245

319

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

103.2

534

1660

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.2

102.6

341

700

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

24.4

102.4

147

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

100.4

1655

9775

127

Kela drug reimbursment

Transplant complication

8.3

99.7

230

289

E87.6

ICD-10 Finland

Hypokalaemia

5.5

98.8

309

591

K74.3

ICD-10 Finland

Primary biliary cirrhosis

23.1

98.8

144

N05CD07

ATC

temazepam; oral

2.6

98.6

857

3742

K76.6

ICD-10 Finland

Portal hypertension

+∞

97.2

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

97.0

2420

16629

P16

ICPC

Acute alcohol abuse

7.9

96.7

229

300

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

95.3

1267

6807

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

5.6

95.3

292

545

N06AB04

ATC

citalopram; systemic

2.2

94.8

1168

6064

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

93.2

738

3048

Z2446

NOMESCO Finland

Social worker

3.5

93.1

477

1467

WW500

NOMESCO Finland

Blood transfusion

4.4

92.8

356

848

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

10.3

92.6

188

189

A10BH01

ATC

sitagliptin; oral

2.7

92.4

705

2846

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

7.2

91.9

233

338

AA1AD

NOMESCO Finland

CT of head and brain

2.1

91.9

1404

7983

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

10.6

91.2

182

177

N05BA01

ATC

diazepam; systemic, rectal

2.5

91.1

849

3835

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.3

89.7

354

866

JN3AD

NOMESCO Finland

Abdominal CT examination

3.0

89.5

568

2036

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

85.6

JJ5AT

NOMESCO Finland

103.0

83.2

I81

ICD-10 Finland

Portal vein thrombosis

25.1

83.2

118

5712A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic cirrhosis of liver

+∞

82.5

Z72.1

ICD-10 Finland

Alcohol use

8.0

82.3

194

252

K29.6

ICD-10 Finland

Other gastritis

10.1

81.4

167

171

C07AG02

ATC

carvedilol; oral

3.1

81.4

484

1656

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.9

79.4

534

1983

UJF32

NOMESCO Finland

Coloscopy

1.9

79.0

1428

8568

ZXD05

NOMESCO Finland

Urgent procedure

1.9

78.5

1632

10289

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

14.9

77.1

131

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.7

76.9

592

2387

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

75.6

1024

5467

M04AA01

ATC

allopurinol; systemic

2.2

75.1

887

4458

TK800

NOMESCO Finland

Hemodialysis

5.2

74.8

243

484

A46

ICD-10 Finland

Erysipelas

2.2

74.3

887

4477

WX892

NOMESCO Finland

Monitored bed care

2.8

74.1

536

2080

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

7.3

74.0

185

263

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

73.4

711

3246

L04AA06

ATC

mycophenolic acid; systemic

6.4

73.4

200

321

K29.2

ICD-10 Finland

Alcoholic gastritis

23.5

73.3

106

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

4.6

72.5

263

590

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

72.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.2

71.5

285

702

N05AB01

ATC

dixyrazine; systemic

6.8

71.0

185

279

57101

ICD-8 Finland

Cirrhosis of liver, Degeneratio hepatica adiposa alcoholica

+∞

71.0

SPAT1265

SPAT

Breathalyser

9.3

70.4

150

165

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

29.3

70.0

UJD02

NOMESCO Finland

Gastroscopy

3.4

69.1

365

1141

K85

ICD-10 Finland

Acute pancreatitis

5.8

68.2

201

357

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.6

68.0

332

976

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.0

67.5

193

330

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

67.4

679

3151

S01.0

ICD-10 Finland

Open wound of scalp

2.6

66.1

522

2128

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.9

65.8

227

483

K83.0

ICD-10 Finland

Cholangitis

6.8

65.0

169

254

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.2

64.9

211

421

A10BB12

ATC

glimepiride; oral

2.6

64.6

519

2133

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

23.7

64.6

K29.7

ICD-10 Finland

Gastritis, unspecified

4.0

64.5

271

700

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.8

63.5

445

1687

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

50.7

62.3

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

61.8

1600

10643

57100

ICD-8 Finland

Cirrhosis of liver, Cirrhosis cum alcoholismo

+∞

60.5

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

17.0

59.1

A10AE05

ATC

insulin detemir; parenteral

2.9

59.0

381

1369

I50.9

ICD-10 Finland

Heart failure, unspecified

2.1

58.8

795

4192

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.0

58.7

913

5089

A41.9

ICD-10 Finland

Sepsis, unspecified

3.5

58.3

290

864

A28

ICPC

Limited function/disability NOS

2.0

58.1

809

4316

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

57.8

399

1496

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

11.0

57.6

112

104

L04AD01

ATC

ciclosporin; systemic

5.3

57.4

183

357

I86.4

ICD-10 Finland

Gastric varices

195.5

56.1

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

56.0

1297

8278

N06AB10

ATC

escitalopram; oral

2.0

56.0

853

4709

K86.1

ICD-10 Finland

Other chronic pancreatitis

8.0

55.9

130

166

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

54.8

473

2013

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

54.5

324

1100

S42.2

ICD-10 Finland

Fracture of upper end of humerus

3.4

54.4

278

846

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

54.0

53.8

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.4

53.7

272

821

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

8.5

53.4

120

145

ZX120

NOMESCO Finland

Intravenous

2.3

53.3

536

2470

SPAT1262

SPAT

Handing over of treatment supplies

1.8

53.1

1029

6182

R41.0

ICD-10 Finland

Disorientation, unspecified

3.8

52.3

234

639

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

5.7

51.5

154

279

R53

ICD-10 Finland

Malaise and fatigue

1.9

51.4

945

5569

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

16.1

51.3

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

51.2

870

4986

N05AA02

ATC

levomepromazine; systemic

3.1

50.7

294

978

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

50.7

195

464

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

18.8

50.5

N06AX16

ATC

venlafaxine; oral

2.1

50.2

617

3108

K70

ICD-10 Finland

Alcoholic liver disease

175.1

50.0

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

49.0

198

Kela drug reimbursment

Sorafenib

22.9

48.3

JN4CD

NOMESCO Finland

Very extensive body CT

3.0

48.3

294

1014

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.5

47.8

176

401

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

47.7

1436

9807

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

5.4

47.6

149

285

G93.4

ICD-10 Finland

Encephalopathy, unspecified

17.9

47.1

R4110

NOMESCO Finland

Physiotherapy

1.7

46.6

1312

8788

V03AA01

ATC

4.2

45.9

182

446

N06AB03

ATC

fluoxetine; oral

2.1

45.8

602

3115

W19

ICD-10 Finland

Unspecified fall

2.2

45.2

505

2433

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

+∞

44.8

E87.5

ICD-10 Finland

Hyperkalaemia

4.7

44.1

154

333

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

44.1

356

1459

WX872

NOMESCO Finland

Intensive care

2.6

43.7

343

1381

E87.2

ICD-10 Finland

Acidosis

9.7

43.7

N02AA05

ATC

oxycodone; systemic

1.8

43.2

783

4561

J01MA02

ATC

ciprofloxacin; systemic

1.5

43.1

1932

14497

5713X

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic liver damage, unspecified

+∞

42.8

R11

ICD-10 Finland

Nausea and vomiting

2.4

42.7

377

1617

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

6.3

42.3

115

185

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.9

41.9

722

4132

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.4

41.8

364

1552

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

9.9

41.7

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

50.5

41.7

WX882

NOMESCO Finland

High dependency care

3.5

41.6

203

596

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

40.9

488

2417

205

Kela drug reimbursment

Chronic hypertension

1.6

40.8

1497

10670

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

40.7

723

4175

E66.00

ICD-10 Finland

Metabolic syndrome

2.6

40.7

325

1319

N19

ICD-10 Finland

Unspecified kidney failure

3.1

40.5

234

779

A10BH05

ATC

linagliptin; oral

2.7

40.4

301

1178

Z2221

NOMESCO Finland

Medical doctor

1.6

40.2

1260

8624

R60.0

ICD-10 Finland

Localized oedema

2.0

40.0

551

2896

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

4.3

39.9

153

364

S06.0

ICD-10 Finland

Concussion

2.1

39.5

498

2526

TJA10

NOMESCO Finland

Laparocentesis

17.4

39.3

N05CF02

ATC

zolpidem; oral

1.8

39.1

788

4739

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

64.8

39.1

N05BA12

ATC

alprazolam; oral

2.1

39.0

496

2524

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.8

38.9

113

198

A02BC01

ATC

omeprazole; systemic

1.6

38.7

1319

9206

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

4.1

38.5

156

391

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.9

38.4

163

426

WX002

NOMESCO Finland

Sedation and analgesia

1.7

38.2

959

6163

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

38.1

362

1613

N40

ICD-10 Finland

Hyperplasia of prostate

0.6

38.1

622

9843

J01MA12

ATC

levofloxacin; systemic

1.7

37.7

966

6245

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

16.2

37.6

I85

ICD-10 Finland

Oesophageal varices

+∞

37.5

C07AB07

ATC

bisoprolol; oral

1.5

37.5

2326

18546

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

37.5

311

1289

M10.9

ICD-10 Finland

Gout, unspecified

2.2

37.3

418

2011

R50.9

ICD-10 Finland

Fever, unspecified

1.8

37.3

682

3970

K86.0

ICD-10 Finland

Alcohol-induced chronic pancreatitis

32.3

36.6

Z3226

NOMESCO Finland

Physiotherapist

1.7

36.3

888

5656

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.1

36.3

128

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

10.3

36.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

35.9

552

3022

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.3

35.6

190

597

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

4.9

35.6

119

246

N17.8

ICD-10 Finland

Other acute renal failure

5.3

35.5

112

217

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

6.0

35.5

100

169

K65.0

ICD-10 Finland

Acute peritonitis

5.6

35.5

106

193

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

35.4

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.4

35.4

131

301

L01XE05

ATC

[U] sorafenib; oral

24.0

35.3

L28

ICPC

Limited function/disability (L)

1.7

35.0

750

4587

K86.3

ICD-10 Finland

Pseudocyst of pancreas

8.4

35.0

SPAT1254

SPAT

Administration of medicine

1.8

34.8

683

4061

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

15.6

34.7

N06AA12

ATC

doxepin; systemic

2.5

34.6

296

1248

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

34.5

705

4249

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.4

34.1

296

1258

JN4BD

NOMESCO Finland

Extensive body CT

1.8

34.0

597

3421

Z51.5

ICD-10 Finland

Palliative care

2.2

33.8

348

1611

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

36.1

33.7

A12BA01

ATC

potassium chloride; oral

2.5

33.4

267

1084

309

Kela drug reimbursment

Nalmefene and naltrexone

11.0

33.3

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

10.6

33.3

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

33.2

228

849

F05.9

ICD-10 Finland

Delirium, unspecified

3.7

33.2

149

409

I50.0

ICD-10 Finland

Congestive heart failure

2.1

33.2

404

2013

Z3231

NOMESCO Finland

Registered nurse

1.5

33.1

1290

9233

K75.4

ICD-10 Finland

Autoimmune hepatitis

41.3

33.1

E86

ICD-10 Finland

Volume depletion

3.4

33.0

166

500

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

11.0

32.8

J01FF01

ATC

clindamycin; systemic

1.5

32.7

1247

8875

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.2

32.5

176

560

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

49.1

32.5

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.5

32.4

262

1072

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

32.4

858

5566

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

32.4

513

2833

T74.1

ICD-10 Finland

Physical abuse

5.1

32.2

104

208

SPAT1247

SPAT

Outpatient detoxication and monitoring

8.3

32.1

N05BE01

ATC

buspirone; oral

3.2

32.0

178

577

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

18.3

31.7

JJA20

NOMESCO Finland

Open biopsy of liver

22.1

31.7

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

16.1

31.5

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.2

31.3

170

542

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.0

31.3

183

615

L04AX01

ATC

azathioprine; systemic

2.7

31.3

230

892

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.5

31.2

252

1031

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.9

31.2

199

708

SPAT1240

SPAT

Therapeutic discussion

2.1

31.0

378

1883

S97

ICPC

Chronic ulcer skin

2.3

31.0

311

1419

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

2.9

30.9

199

711

R04.0

ICD-10 Finland

Epistaxis

2.1

30.7

390

1975

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.8

30.7

211

786

SPAT1227

SPAT

Substance abuse rehabilitation

6.8

30.6

116

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

26.4

30.5

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.3

30.3

294

1322

D73.1

ICD-10 Finland

Hypersplenism

32.7

29.9

V03AB30

ATC

5.7

29.8

155

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

7.9

29.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

29.3

587

3501

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

12.8

29.3

JN4AD

NOMESCO Finland

Body CT examination

2.0

29.2

412

2175

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

29.2

335

1627

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

29.1

141

413

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

29.0

244

1021

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

28.9

575

3422

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.4

28.9

122

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

28.1

28.8

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

8.1

28.7

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

5.6

28.6

151

E66.9

ICD-10 Finland

Obesity, unspecified

3.0

28.4

170

580

N06AB06

ATC

sertraline; oral

1.9

27.8

427

2326

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

27.8

557

3320

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

25.5

27.4

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.3

27.4

266

1194

UJK02

NOMESCO Finland

ERCP

3.0

27.4

161

544

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.4

27.3

241

1032

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.2

27.1

275

1262

G72.8

ICD-10 Finland

Other specified myopathies

3.9

27.1

114

297

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

27.1

863

5848

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

27.0

242

1046

W10

ICD-10 Finland

Fall on and from stairs and steps

2.3

26.8

249

1096

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

15.3

26.8

160

Kela drug reimbursment

exenatide

3.2

26.7

142

447

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.0

26.6

177

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

26.6

519

3068

N06AX03

ATC

mianserin; oral

2.3

26.6

259

1168

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

26.5

1229

9060

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

2.4

26.5

238

1028

R06.0

ICD-10 Finland

Dyspnoea

1.5

26.5

1096

7885

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.5

26.2

209

848

H02AB06

ATC

prednisolone; systemic

1.4

26.2

2074

16898

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

5.4

26.2

151

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

26.1

206

834

S22.3

ICD-10 Finland

Fracture of rib

2.0

26.0

338

1727

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

60.3

26.0

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.2

25.8

264

1218

K76.89

ICD-10 Finland

Other specified diseases of liver

16.5

25.7

N06AB05

ATC

paroxetine; oral

2.2

25.7

276

1301

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.6

25.5

192

756

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.9

25.3

158

556

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.7

25.2

178

673

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

6.0

25.0

119

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

24.9

188

741

A10BB01

ATC

glibenclamide; oral

2.3

24.9

242

1090

K85.0

ICD-10 Finland

Idiopathic acute pancreatitis

6.0

24.9

116

R94.5

ICD-10 Finland

Abnormal results of liver function studies

5.3

24.8

148

N03AX16

ATC

pregabalin; oral

1.5

24.7

1025

7362

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

9.4

24.6

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

5.3

24.2

140

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.8

24.2

105

282

OAB43

SPAT

0.4

24.2

136

2976

WX730

NOMESCO Finland

Conventional respirator

3.5

24.2

117

344

5770D

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA NONHAEMORHAGICA]

7.3

24.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.4

24.1

206

A41.8

ICD-10 Finland

Other specified sepsis

3.4

24.1

117

345

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

4.7

24.0

180

RS220

NOMESCO Finland

4.4

23.7

196

H02AB04

ATC

methylprednisolone; systemic

1.6

23.7

638

4129

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

9.3

23.7

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

3.2

23.7

126

398

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.1

23.5

130

422

E000001

ATC

1.5

23.5

831

5754

S82.6

ICD-10 Finland

Fracture of lateral malleolus

2.1

23.5

287

1430

E66.8

ICD-10 Finland

Other obesity

2.3

23.4

216

948

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.6

23.4

108

306

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

23.3

316

1641

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

23.2

648

4233

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.5

23.0

189

779

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

12.5

23.0

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

22.9

158

593

K83.1

ICD-10 Finland

Obstruction of bile duct

3.9

22.8

247

F10.8

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Other mental and behavioural disorders

17.6

22.6

J01DA01

ATC

[U] cefalexin; systemic

1.3

22.4

2759

23904

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

22.4

533

3335

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

5.7

22.4

116

P03

ICPC

Feeling depressed

2.1

22.3

277

1390

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.1

22.3

218

E51.2

ICD-10 Finland

Wernicke encephalopathy

16.8

22.2

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

16.8

22.2

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

4.9

22.1

151

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

11.5

22.1

D64.8

ICD-10 Finland

Other specified anaemias

3.4

22.1

109

326

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

22.1

201

876

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

14.3

22.1

K74.1

ICD-10 Finland

Hepatic sclerosis

+∞

21.9

X58

ICD-10 Finland

Exposure to other specified factors

1.6

21.9

583

3759

K08.3

ICD-10 Finland

Retained dental root

1.9

21.8

345

1898

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.7

21.7

464

2814

3A422

NOMESCO Finland

20.1

21.6

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.1

21.6

265

1323

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

220.9

21.6

X45

ICD-10 Finland

Accidental poisoning by and exposure to alcohol

8.2

21.6

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

21.5

140

506

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

5.9

21.4

103

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

21.3

1259

9651

D69.5

ICD-10 Finland

Secondary thrombocytopenia

10.1

21.3

K22.1

ICD-10 Finland

Ulcer of oesophagus

3.1

21.2

119

392

S42.0

ICD-10 Finland

Fracture of clavicle

2.6

21.1

157

613

JAH00

NOMESCO Finland

Laparotomy

2.7

21.0

149

567

RS120

NOMESCO Finland

15.5

21.0

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

21.0

474

2920

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

21.0

287

1494

D05AX52

ATC

calcipotriol, combinations; topical

2.0

20.9

274

1405

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.2

20.8

109

342

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.1

20.7

230

1101

N05AH03

ATC

olanzapine; systemic

2.1

20.6

243

1193

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

110.5

20.6

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.8

20.5

130

464

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.0

20.4

121

414

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

4.8

20.4

143

3AC01

NOMESCO Finland

4.7

20.3

152

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

20.1

20.3

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

20.3

469

2906

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.4

20.3

A10BJ02

ATC

liraglutide; parenteral

2.7

20.3

137

508

ZXD35

NOMESCO Finland

Usual procedure

2.4

20.2

178

764

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

20.2

377

5879

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

20.2

297

1589

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

4.5

20.1

163

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.1

20.0

196

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

20.0

336

1884

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

5.9

20.0

D25

ICPC

Abdominal distension

3.5

20.0

266

A08

ICPC

Swelling

2.3

20.0

188

835

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

20.0

311

1702

R01AD12

ATC

fluticasone furoate; nasal

0.7

19.9

546

7854

N05AD01

ATC

haloperidol; systemic

2.4

19.9

167

700

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

4.1

19.8

189

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

19.7

463

2882

A04

ICPC

Weakness/tiredness general

1.6

19.5

485

3065

N05AF03

ATC

chlorprothixene; systemic

2.7

19.5

136

512

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

3.7

19.4

232

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

19.3

131

487

A10BG03

ATC

pioglitazone; oral

2.5

19.3

151

611

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.9

19.3

130

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.5

19.2

150

605

K07

ICPC

Swollen ankles/oedema

2.2

19.2

196

905

N05AD03

ATC

melperone; systemic

3.5

19.2

270

UJF92

NOMESCO Finland

Capsular endoscopy

3.1

19.2

108

357

2910A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal delirium

9.8

19.0

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.7

19.0

130

486

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

18.9

224

1101

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

10.7

18.9

WVA20

NOMESCO Finland

Medicine administration

2.8

18.8

121

436

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

5.8

18.8

2918A

ICD-9 Finland

Alcoholic psychoses, Other specified alcoholic psychosis

9.6

18.8

A10BD07

ATC

metformin and sitagliptin; systemic

2.0

18.8

236

1189

Y90.8

ICD-10 Finland

Blood alcohol level of 240 mg/100 ml or more

13.4

18.7

323

Kela drug reimbursment

Sorafenib

20.9

18.6

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

7.6

18.5

A10BX07

ATC

[U] liraglutide; parenteral

3.4

18.4

263

M01AB01

ATC

indometacin; systemic, rectal

1.7

18.4

408

2497

P01AB01

ATC

metronidazole; oral, rectal

1.3

18.4

1507

12144

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

18.4

405

2476

P29

ICPC

Psychological sympt/compl other

2.3

18.3

177

797

N06AX05

ATC

trazodone; oral

2.9

18.3

114

404

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

11.0

18.2

ZXE00

NOMESCO Finland

One hour or less

1.3

18.1

1647

13479

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.1

18.0

172

F34.1

ICD-10 Finland

Dysthymia

2.5

18.0

142

576

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

18.0

116

420

30300

ICD-8 Finland

Alcoholism, Episodic excessive drinking

3.6

18.0

227

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

4.9

17.9

119

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

17.8

1332

10575

1324

FHL

Esophagoscopy and sclerotherapy

66.8

17.7

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

17.7

182

842

P76

ICPC

Depressive disorder

2.1

17.7

194

924

5CM18

NOMESCO Finland

6.6

17.6

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.5

17.6

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.5

17.6

135

539

R60.1

ICD-10 Finland

Generalized oedema

6.3

17.6

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

17.4

273

1497

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

17.4

213

1063

N30.0

ICD-10 Finland

Acute cystitis

1.6

17.4

448

2859

SPAT1255

SPAT

Intravenous administration of medicine

1.8

17.4

306

1747

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

17.3

134

538

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

2.1

17.3

191

912

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.1

17.3

187

888

D10

ICPC

Vomiting

2.3

17.2

160

706

A02BC03

ATC

lansoprazole; oral

1.4

17.2

1262

9979

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

17.1

243

1286

E0000UV

ATC

1.3

17.1

1536

12524

C10AA07

ATC

rosuvastatin; oral

0.7

17.0

617

8461

D23

ICPC

Hepatomegaly

50.2

17.0

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

16.9

243

1289

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

16.9

2719

24002

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.9

16.8

174

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

12.1

16.8

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

14.1

16.8

N06AA09

ATC

amitriptyline; systemic

1.6

16.7

417

2635

R02

ICPC

Shortness of breath/dyspnoea

1.6

16.7

477

3123

ZZA00

NOMESCO Finland

Split skin graft

2.2

16.7

163

740

F32

ICD-10 Finland

Depressive episode

2.2

16.6

178

841

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

16.6

262

1439

30310

ICD-8 Finland

Alcoholism, Habitual excessive drinking

4.1

16.6

157

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.1

16.6

157

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

16.5

337

2015

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

16.5

243

1303

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

16.4

453

2938

C09AA02

ATC

enalapril; systemic

1.4

16.3

925

6995

R10.0

ICD-10 Finland

Acute abdomen

2.4

16.2

143

618

K29.1

ICD-10 Finland

Other acute gastritis

3.3

16.1

248

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.9

16.1

340

A10BK03

ATC

empagliflozin; oral

1.7

16.1

333

1997

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

16.1

109

407

UJC12

NOMESCO Finland

Flexible oesophagoscopy

4.6

16.1

120

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

0.6

16.1

323

4966

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.1

1327

10664

EBA30

NOMESCO Finland

Excision of root of tooth

1.8

16.1

263

1464

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

16.0

167

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

5.1

16.0

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

18.5

16.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

16.0

1636

13558

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

13.6

15.9

N03AX09

ATC

lamotrigine; oral

2.2

15.9

160

735

K65.9

ICD-10 Finland

Peritonitis, unspecified

8.5

15.9

K26.4

ICD-10 Finland

Duodenal ulcer, chronic or unspecified with haemorrhage

6.2

15.9

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

0.6

15.9

275

4370

N05BB01

ATC

hydroxyzine; systemic

1.9

15.8

248

1362

RS221

NOMESCO Finland

3.1

15.8

280

N03AX14

ATC

levetiracetam; systemic

2.4

15.7

130

541

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

15.7

319

1905

A10BX04

ATC

[U] exenatide; parenteral

3.5

15.7

211

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.0

15.7

156

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

15.7

M01AH05

ATC

etoricoxib; oral

0.8

15.7

1862

21614

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

3.7

15.6

186

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

15.6

261

1464

S76

ICPC

Skin infection other

1.9

15.6

218

1146

P01

ICPC

Feeling anxious/nervous/tense

1.9

15.5

242

1326

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.6

15.5

219

3652

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

15.5

151

683

S00.0

ICD-10 Finland

Superficial injury of scalp

2.8

15.4

101

370

C10AC01

ATC

colestyramine; oral

2.4

15.4

126

523

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

10.8

15.4

WW200

SPAT

0.5

15.4

133

2540

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

4.5

15.4

121

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

15.4

676

8994

K65.8

ICD-10 Finland

Other peritonitis

9.4

15.4

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

5.3

15.4

T89

ICPC

Diabetes insulin dependent

2.2

15.3

161

755

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.7

15.2

104

391

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

15.2

615

4351

P19

ICPC

Drug abuse

5.4

15.2

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.7

15.2

106

401

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.3

15.2

142

632

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

15.2

110

427

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

13.1

15.1

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.6

15.1

107

411

K29.8

ICD-10 Finland

Duodenitis

4.0

15.1

152

F10.04

ICD-10 Finland

Alcohol-related acute intoxication with hallucinations

23.4

15.1

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.6

15.1

235

3831

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

15.0

856

6470

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.5

15.0

113

450

212

Kela drug reimbursment

Gout

2.5

14.9

119

487

G04CB02

ATC

dutasteride; oral

0.5

14.9

116

2281

K20

ICD-10 Finland

Oesophagitis

3.0

14.8

298

C01AA05

ATC

digoxin; systemic

1.6

14.8

371

2348

Y07

ICD-10 Finland

Other maltreatment

4.8

14.7

100

Z50.2

ICD-10 Finland

Alcohol rehabilitation

9.7

14.6

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.1

14.6

262

4561A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices without mention of bleeding

+∞

14.6

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

14.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

14.6

421

2762

R40.2

ICD-10 Finland

Coma, unspecified

3.9

14.6

157

162

Kela drug reimbursment

liraglutide

3.2

14.5

230

V03AE01

ATC

polystyrene sulfonate; oral

3.1

14.5

263

OAA67

SPAT

0.4

14.5

1349

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.6

14.5

183

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

150.4

14.5

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

8.4

14.4

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

7.3

14.4

2BB01

NOMESCO Finland

36.1

14.4

TJA00

NOMESCO Finland

Puncture of peritoneum

36.1

14.4

L76

ICPC

Fracture: other

2.4

14.4

122

517

G04CA52

ATC

tamsulosin and dutasteride; systemic

0.6

14.4

220

3598

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

7.5

14.4

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

14.3

214

1153

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.9

14.3

300

B82

ICPC

Anaemia other/unspecified

2.4

14.3

119

501

SPAT1216

SPAT

Assessment of functional ability

1.4

14.3

623

4478

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

27.2

14.3

OAA80

SPAT

0.3

14.3

918

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.8

14.2

234

1309

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

9.1

14.2

D07XC01

ATC

betamethasone, combinations; topical

1.5

14.1

518

3590

TK810

NOMESCO Finland

Hemofiltration

4.3

14.1

123

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.3

14.1

967

9128

FHL

Open reduction and osteosynthesis

2.3

14.1

129

568

K71.1

ICD-10 Finland

Toxic liver disease with hepatic necrosis

42.6

14.1

F32.1

ICD-10 Finland

Moderate depressive episode

2.1

14.1

162

792

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.3

14.0

125

541

B80

ICPC

Iron deficiency anaemia

2.8

14.0

309

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.2

14.0

137

624

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

6.4

13.9

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

7.5

13.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

13.9

257

1492

R4190

NOMESCO Finland

Nutritional therapy

2.2

13.9

143

666

G04CA01

ATC

alfuzosin; oral

0.6

13.9

330

4905

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.0

13.8

184

953

C09AA05

ATC

ramipril; oral

1.3

13.8

1144

9161

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

13.8

148

702

SPAT1234

SPAT

Support of social functional capacity

1.9

13.8

206

1113

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

4.9

13.8

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

13.8

362

2320

Z72.2

ICD-10 Finland

Drug use

7.1

13.8

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

20.1

13.8

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

13.7

315

1946

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

13.7

235

C07AB02

ATC

metoprolol; systemic

1.4

13.7

904

6990

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.3

13.6

131

590

A07EA06

ATC

budesonide; oral, local oral

2.3

13.6

131

590

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

13.6

430

2883

D07AB08

ATC

desonide; topical

1.6

13.6

389

2546

D07AA02

ATC

hydrocortisone; topical

1.5

13.6

484

3336

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

7.9

13.5

A07AA09

ATC

vancomycin; oral

3.4

13.5

194

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.2

13.5

221

JAH01

NOMESCO Finland

Laparoscopy

2.1

13.5

153

744

N03AF01

ATC

carbamazepine; oral, rectal

1.8

13.5

232

1316

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

34.1

13.5

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.2

13.5

140

654

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

0.5

13.4

107

2089

C10AA05

ATC

atorvastatin; oral

0.8

13.4

1271

15252

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

25.8

13.3

57309

ICD-8 Finland

Other diseases of liver, Unspecified

7.7

13.3

R16.0

ICD-10 Finland

Hepatomegaly, not elsewhere classified

21.2

13.3

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.7

13.3

350

E83.1

ICD-10 Finland

Disorders of iron metabolism

5.9

13.3

N07BB04

ATC

naltrexone; oral

8.1

13.3

NBJ62

NOMESCO Finland

Internal fixation of fracture of shoulder or upper arm using plate and screws, humerus

3.4

13.2

192

XX4BW

NOMESCO Finland

10.5

13.2

J94.8

ICD-10 Finland

Other specified pleural conditions

2.7

13.2

328

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.0

13.2

127

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

4.5

13.1

104

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.4

13.1

783

5953

B17.1

ICD-10 Finland

Acute hepatitis C

12.2

13.1

474

NOMESCO Finland

15.0

13.1

M10.0

ICD-10 Finland

Idiopathic gout

2.0

13.1

167

852

SPAT1088

SPAT

Blood transfusion

4.8

12.9

UJK12

NOMESCO Finland

Peroral cholangioscopy

7.4

12.9

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

12.9

277

1680

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.6

12.9

251

3891

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

12.9

187

1002

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

12.8

235

1359

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

6.9

12.8

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

5.3

12.8

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

6.6

12.7

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

14.0

12.7

OAB48

SPAT

0.4

12.7

1454

B01AB05

ATC

enoxaparin; parenteral

1.3

12.7

1259

10322

R83

ICPC

Respiratory infection other

0.7

12.6

371

5296

N03AG01

ATC

valproic acid; systemic, rectal

1.8

12.6

227

1307

I51.7

ICD-10 Finland

Cardiomegaly

5.2

12.5

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

5.9

12.5

K76.4

ICD-10 Finland

Peliosis hepatis

+∞

12.5

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.5

12.5

401

A10BB07

ATC

glipizide; oral

2.9

12.5

263

29100

ICD-8 Finland

Alcoholic psychosis, Delirium tremens

8.7

12.5

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

7.3

12.4

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

12.4

775

5930

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

12.4

373

2471

L17

ICPC

Foot/toe symptom/complaint

1.3

12.4

960

7595

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.6

12.4

174

2906

ZXA00

NOMESCO Finland

Right side

1.3

12.3

1137

9225

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

12.3

134

640

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

12.3

144

712

N06AA06

ATC

trimipramine; systemic

2.3

12.2

116

522

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

12.2

1154

13881

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

12.2

285

7803A

ICD-9 Finland

General symptoms, Convulsions

4.1

12.1

113

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.7

12.1

296

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

15.9

12.1

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.4

12.1

174

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

12.1

1516

12794

D07AC01

ATC

betamethasone; topical

1.3

12.1

1387

11575

P18

ICPC

Medication abuse

5.4

12.0

2BD01

NOMESCO Finland

8.2

12.0

N06AG02

ATC

moclobemide; oral

1.9

12.0

185

1011

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

12.0

409

2789

T51.0

ICD-10 Finland

Toxic effect: Ethanol

5.7

11.9

SPAT1229

SPAT

Assessment of need for aid

1.6

11.9

320

2064

D01BA02

ATC

terbinafine; oral; topical

0.7

11.9

721

9184

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.0

11.8

144

722

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.9

11.8

238

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

6.1

11.8

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.9

11.8

177

958

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

11.7

139

687

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.9

11.7

251

A02BA03

ATC

famotidine; systemic

1.9

11.7

177

963

XKD00

NOMESCO Finland

Uroflowmetry

0.7

11.7

497

6671

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

11.7

304

1946

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

11.7

214

1240

B03XA02

ATC

darbepoetin alfa; parenteral

2.5

11.7

377

J01DB01

ATC

cefalexin; oral

1.3

11.7

3594

33503

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

11.7

305

1953

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.3

11.6

104

455

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

6.0

11.6

T68

ICD-10 Finland

Hypothermia

5.3

11.6

D50

ICD-10 Finland

Iron deficiency anaemia

2.9

11.6

247

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.6

11.6

138

RS222

NOMESCO Finland

3.1

11.5

208

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.2

11.5

186

2913A

ICD-9 Finland

Alcoholic psychoses, Alcohol withdrawal hallucinosis

11.1

11.5

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

11.1

11.5

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

11.5

283

1785

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.9

11.5

155

809

OAB40

SPAT

10.0

11.5

5353A

ICD-9 Finland

Gastritis and duodenitis, Alcoholic gastritis

9.2

11.5

H02AB07

ATC

prednisone; oral

1.4

11.5

553

4044

F10.6

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Amnesic syndrome

13.6

11.4

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

11.4

111

506

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.7

11.4

356

5033

A10AB06

ATC

insulin glulisine; parenteral

3.1

11.4

193

S20.2

ICD-10 Finland

Contusion of thorax

1.8

11.4

202

1157

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.7

11.3

242

1468

RS122

NOMESCO Finland

7.8

11.3

N05CD08

ATC

midazolam; nasal, systemic

2.3

11.3

430

G37.2

ICD-10 Finland

Central pontine myelinolysis

35.1

11.3

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

8.9

11.2

5770F

ICD-9 Finland

Diseases of pancreas, Acute pancreatitis[PANCREATITIS ACUTA ALCOHOLICA RECIDIVANS]

9.6

11.2

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

11.2

390

2673

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

11.2

251

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.2

11.1

180

I95.9

ICD-10 Finland

Hypotension, unspecified

2.7

11.1

276

RS230

NOMESCO Finland

4.8

11.1

K77

ICPC

Heart failure

2.5

11.1

361

A10BH02

ATC

vildagliptin; oral

2.3

11.1

100

439

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

11.1

158

843

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.8

11.1

247

M05BA04

ATC

alendronic acid; oral

1.6

11.0

278

1762

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

11.0

305

4413

R03BB04

ATC

tiotropium bromide; inhalant

1.4

11.0

458

3253

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.1

11.0

198

SPAT1274

SPAT

Brief intervention in person with addiction symptoms

6.1

11.0

X31

ICD-10 Finland

Exposure to excessive natural cold

8.6

11.0

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.3

10.9

424

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

10.9

1003

8112

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

10.9

107

488

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.7

10.9

207

1211

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.2

10.9

105

477

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

43.4

10.9

K86.2

ICD-10 Finland

Cyst of pancreas

3.7

10.9

125

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

4.2

10.9

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.1

10.9

101

I50

ICD-10 Finland

Heart failure

2.0

10.8

137

697

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

10.8

1022

8296

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

4.3

10.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

10.8

1371

A02BC05

ATC

esomeprazole; systemic

1.2

10.8

1640

14111

N07BA03

ATC

varenicline; oral

1.8

10.7

191

1098

E13.7

ICD-10 Finland

Other specified diabetes mellitus, with multiple complications

9.6

10.7

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.4

10.7

357

B01AA03

ATC

warfarin; systemic

1.3

10.7

911

7287

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.1

10.7

180

NH1AD

NOMESCO Finland

Ankle and foot CT

2.4

10.7

376

L04AA10

ATC

sirolimus; oral

17.8

10.7

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

10.7

365

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.7

10.7

207

1222

S06.3

ICD-10 Finland

Focal brain injury

2.8

10.7

248

E66.0

ICD-10 Finland

Obesity due to excess calories

3.0

10.7

197

N06AB08

ATC

fluvoxamine; oral

2.1

10.7

118

570

X57

ICD-10 Finland

Unspecified privation

2.3

10.6

437

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.7

10.6

123

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

10.6

1567

13429

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

60.1

10.6

UJD10

SPAT

2.8

10.6

243

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.1

10.6

120

586

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

0.8

10.5

761

9488

KED22

NOMESCO Finland

Transurethral resection of prostate

0.5

10.5

112

2012

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.7

10.5

229

1400

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

10.5

109

512

J01CF05

ATC

flucloxacillin; systemic

1.9

10.5

153

824

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

10.5

136

699

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

6.2

10.4

F31

ICD-10 Finland

Bipolar affective disorder

3.4

10.4

146

K51.5

ICD-10 Finland

Left sided colitis

2.2

10.4

106

496

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

0.6

10.3

222

3372

F10.74

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol otherwise permanently impaired intelligence

16.0

10.3

F10.50

ICD-10 Finland

Alcohol-related psychosis is schizophrenic

12.0

10.3

SPAT1281

SPAT

Other administrative function

1.6

10.3

297

1951

3A064

NOMESCO Finland

4.5

10.3

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.1

10.3

117

572

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

9.6

10.2

Y91.2

ICD-10 Finland

Severe alcohol intoxication

23.4

10.2

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

10.2

321

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

10.2

300

4286

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.0

10.2

121

603

P27

ICPC

Fear of mental disorder

3.8

10.1

108

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

3.4

10.1

144

S02.30

ICD-10 Finland

Fracture of orbital floor, closed

3.4

10.1

144

ZX108

NOMESCO Finland

Inhalation

3.4

10.1

139

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

10.1

574

4317

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.4

10.1

K80.8

ICD-10 Finland

Other cholelithiasis

2.7

10.1

257

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.8

10.1

226

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.9

10.1

211

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

10.1

444

3192

A10BK01

ATC

dapagliflozin; oral

1.7

10.1

192

1129

ZY010

NOMESCO Finland

Hospital outpatient

1.9

10.0

149

806

L30.3

ICD-10 Finland

Infective dermatitis

1.9

10.0

145

778

JKA20

NOMESCO Finland

Cholecystectomy

2.0

10.0

127

651

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.1

10.0

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

2.1

10.0

113

552

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.2

10.0

103

483

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.1

10.0

106

505

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

40.1

10.0

L01EX02

ATC

sorafenib; oral

40.1

10.0

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

9.9

262

1684

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2857

14848

2.86

323.31

5.1

2.6

u/l

60.9

59.0

0.45

2696

13778

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

222

26.51

321.34

3.6

1.7

—

(3033658) Prothrombin time (PT) actual/Normal

2525

12232

2.91

307.65

14.1

4.0

70.0

87.4

174.11

2433

11955

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4036

24701

3.18

307.65

18.3

6.4

umol/l

26.3

11.7

87.28

3935

23510

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

916

515

21.01

307.65

1.2

1.1

g/l

1.7

1.5

9.56

822

465

(3007566) Smooth muscle Ab [Titer] in Serum

1682

1021

22.97

307.65

1.4

1.2

titre

92.6

154.5

0.90

179

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

372

253

15.66

307.65

1.1

1.0

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1254

538

29.61

307.65

3.6

2.3

u/ml

1266.7

266.9

0.71

1233

528

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2167

7010

4.38

307.65

3.0

2.7

g/l

2.2

2.3

3.59

1989

6535

(3028026) IgM [Mass/volume] in Serum or Plasma

1711

2543

9.19

307.65

1.5

1.9

g/l

1.6

1.4

2.02

1559

2309

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

570

697

8.98

307.65

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2028

5318

5.37

307.65

7.7

2.7

umol/l

21.5

8.5

31.03

1879

4694

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

393

344

12.20

307.65

1.3

1.2

titre

177.1

127.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

637

305

23.39

307.65

1.3

1.2

—

(4281824)

420

327

13.79

307.65

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1820

918

28.68

307.65

5.9

1.9

umol/l

45.1

31.1

21.62

1642

771

(3002331) Protein [Mass/volume] in Peritoneal fluid

384

72.17

307.65

1.4

g/l

36.6

30.7

0.13

258

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

393

344

12.20

307.65

1.3

1.2

titre

214.5

145.2

0.59

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

372

253

15.66

307.65

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

562

675

9.13

307.65

1.1

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

589

262

24.96

307.65

1.1

1.0

mg/l

287.4

280.9

0.60

525

235

(3022948) Iron [Moles/volume] in Serum or Plasma

2222

7547

4.19

307.65

3.1

2.7

umol/l

13.0

12.9

0.26

2079

7019

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2142

6599

4.60

307.65

3.1

2.8

26.1

22.7

11.00

1875

5638

(3023487) Leukocytes [#/volume] in Peritoneal fluid

567

101

62.24

307.65

2.5

2.0

e6/l

392.1

8050.0

0.55

402

(3024561) Albumin [Mass/volume] in Serum or Plasma

3825

20641

3.60

307.65

12.2

5.1

g/l

31.9

35.2

177.60

3679

19200

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

513

59.88

307.65

2.4

1.7

e6/l

7643.3

8291.7

0.05

284

(3037522) Nuclear Ab [Titer] in Serum

1884

5530

4.60

307.65

1.5

1.3

titre

418.5

497.8

1.22

434

1089

(3005719) IgG [Mass/volume] in Serum or Plasma

1825

3294

7.68

307.65

2.1

2.7

g/l

13.3

10.3

82.70

1670

3011

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2662

4311

10.72

307.65

4.9

2.1

g/l

0.2

130.79

2389

4019

(3034770) Mitochondria Ab [Titer] in Serum

1655

1003

22.86

307.65

1.3

1.2

titre

702.4

982.4

0.57

(3033799) Differential panel - Peritoneal fluid

507

59.11

307.65

2.5

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1559

4841

4.06

307.65

11.0

7.9

mmol/l

10.7

10.3

0.96

1509

4611

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2076

8134

3.44

307.65

5.2

3.6

mmol/l

0.8

69.16

1976

7611

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2127

5303

5.81

307.65

3.0

1.8

1.5

30.51

1784

4598

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

378

190

21.24

307.65

4.7

2.1

77.4

100.2

12.44

372

182

(3044007) Cell count panel - Peritoneal fluid

437

54.96

307.65

2.4

1.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

385

266

15.45

307.65

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1970

7534

3.47

307.65

1.7

1.5

g/l

4.6

2.5

137.89

1618

4520

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1971

4463

6.23

307.65

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

455

58.79

307.65

1.6

1.3

g/l

9.9

17.0

10.62

323

(40768441) Liver Pathology biopsy report

516

285

19.81

307.65

2.2

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

709

1102

7.21

307.65

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1010

2777

4.21

307.65

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1914

4197

6.37

307.65

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1816

6591

3.58

307.65

7.8

6.5

mmol/l

1.1

1.0

1.70

1718

6137

(44816559) Phosphatidylethanol [Mass/volume] in Blood

707

727

10.96

307.65

2.2

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3277

14963

3.81

307.65

8.9

3.2

u/l

55.3

36.1

20.20

3134

14167

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

272

186

15.31

307.03

4.3

2.3

—

(3042936) Bacteria identified in Isolate by Culture

1697

7000

3.03

289.58

3.1

2.1

—

(3032080) INR in Blood by Coagulation assay

3438

20503

2.71

284.29

16.6

9.8

inr

1.3

0.08

917

5694

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2352

11700

2.72

279.80

3.2

2.2

mg/l

3.8

3.0

30.94

2120

9968

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

335

375

9.43

274.43

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

155

51.37

269.87

3.1

1.5

64.3

53.5

0.87

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

437

723

6.46

254.55

1.2

—

(40768797) Stomach Pathology biopsy report

1522

6358

2.90

248.91

1.4

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

629

1478

4.66

248.01

2.2

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

706

1827

4.27

245.77

3.3

3.7

u/ml

116.0

3154.2

1.30

629

1582

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1188

4357

3.18

244.44

4.5

2.5

u/l

34.4

49.7

0.77

1057

3768

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

834

2451

3.82

243.11

5.6

4.5

mmol/l

23.2

24.1

9.87

770

2194

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1259

4790

3.09

243.05

5.8

4.2

kpa

5.5

5.8

24.22

1215

4645

(3002032) Base excess in Venous blood by calculation

1250

4780

3.07

238.78

5.8

4.2

mmol/l

1.1

1.9

7.42

979

3868

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

581

1355

4.66

230.76

4.1

2.6

g/l

2.9

3.7

25.77

561

1299

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1422

5960

2.85

228.84

3.3

4.5

u/l

252.0

242.3

0.90

1347

5636

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

129

54.97

227.66

3.1

1.4

13.0

23.9

0.70

(3027945) Reticulocytes/100 erythrocytes in Blood

1403

5869

2.85

226.33

2.9

2.5

2.3

1.8

31.89

1256

5196

(3000991) Gas panel - Venous blood

1156

4354

3.08

225.66

12.5

9.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2951

17632

2.40

223.17

4.3

2.8

ug/l

240.5

166.8

10.05

2765

16201

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

794

2395

3.69

221.77

1.9

1.7

g/l

1.1

1.6

33.66

666

2060

(3023368) Bacteria identified in Blood by Culture

2517

14061

2.42

221.27

6.5

4.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

432

817

5.64

218.60

1.3

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1542

6941

2.68

214.20

18.2

26.6

inr

1.5

1.4

0.65

157

993

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

412

761

5.76

213.76

1.3

u/ml

339.3

281.0

2.40

262

466

(3020191) Ethanol [Moles/volume] in Serum or Plasma

288

377

7.99

207.45

2.0

1.3

promille

1.3

1.4

0.31

240

286

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1668

7920

2.56

206.56

3.2

2.1

32.0

30.0

20.39

1612

7701

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

432

903

5.09

195.00

1.5

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

453

1000

4.84

191.63

7.8

6.0

iu/ml

638.9

1933.8

0.44

102

156

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

422

899

4.99

186.16

1.5

u/ml

25.8

16.0

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

182

148

12.67

185.28

1.7

1.5

iu/ml

1629278.6

2132875.0

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1111

4542

2.80

183.41

10.6

7.6

mmol/l

1.9

1.3

20.12

1060

4356

(3042733) HLA Ab [Presence] in Serum

188

164

11.82

183.07

1.9

5.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

207

210

10.19

181.85

34.1

34.4

ug/l

7.3

7.4

0.22

180

192

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

386

797

5.12

176.45

1.4

1.5

u/ml

120.0

118.4

0.07

172

(42870588) Differential panel, method unspecified - Blood

2616

15993

2.18

173.02

7.8

6.0

—

(3024932) HLA-DR beta [Type]

177

154

11.83

172.61

1.0

1.1

—

(3024471) HLA-A [Type]

178

157

11.67

172.05

1.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

453

1091

4.42

171.54

1.3

1.2

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

508

1338

4.07

170.77

5.6

3.3

mg/l

1.8

1.6

5.25

481

1226

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1182

5174

2.62

169.22

3.5

4.4

ug/l

10.6

25.4

2.72

1042

4320

(46235355) HIV 1 and 2 tests - Meaningful Use set

1230

5527

2.56

166.53

1.8

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

203

226

9.28

166.39

36.6

26.3

ug/l

129.5

115.7

1.48

174

183

(3023520) Reticulocytes [#/volume] in Blood

1052

4426

2.69

162.57

3.1

2.6

e9/l

82.9

68.7

16.36

808

3400

(3014576) Chloride [Moles/volume] in Serum or Plasma

1373

6586

2.43

160.82

11.3

7.6

mmol/l

103.7

104.5

5.71

1343

6442

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3194

21470

2.11

160.64

11.3

6.6

mmol/l

1.2

71.95

3011

19508

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

510

1420

3.85

158.27

3.2

2.4

65.5

90.5

56.69

492

1346

(3044640) Blood type and Crossmatch panel - Blood

2413

14835

2.09

151.49

4.3

2.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

869

3455

2.79

149.04

2.0

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3376

23590

2.06

147.69

12.6

7.3

mmol/l

1.2

57.80

2931

19983

(3024354) Oxygen [Partial pressure] in Venous blood

934

3898

2.67

145.44

4.9

3.5

kpa

4.9

4.6

2.50

884

3764

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1251

6121

2.34

137.55

11.4

7.7

kpa

4.8

5.1

17.15

1197

5843

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3978

29909

2.10

137.50

11.2

3.1

u/l

186.3

52.9

175.74

3818

27720

(3019309) Folate [Moles/volume] in Red Blood Cells

1651

9058

2.16

137.14

2.1

1.8

nmol/l

1221.0

1155.7

1.78

1322

6793

(3027801) Oxygen [Partial pressure] in Arterial blood

1250

6121

2.34

137.14

11.4

7.7

kpa

11.5

12.2

6.07

1194

5841

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

452

1279

3.75

136.55

3.4

2.6

222.9

198.0

5.56

432

1219

(3022096) Basophils/100 leukocytes in Blood

3041

20951

1.97

132.65

8.7

6.2

0.7

1.50

2895

19513

(3003396) Base excess in Arterial blood by calculation

1237

6108

2.31

132.60

11.5

7.7

mmol/l

0.0

1.1

9.90

1008

4761

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1937

11434

2.05

131.37

4.1

2.5

—

(3019069) Monocytes/100 leukocytes in Blood

3112

21664

1.96

131.05

9.1

6.5

9.5

8.9

19.15

2966

20242

(3026361) Erythrocytes [#/volume] in Blood

4427

50569

0.44

130.38

53.8

22.7

e12/l

4.1

4.5

307.65

4299

49061

(3010813) Leukocytes [#/volume] in Blood

4428

50576

0.44

130.38

53.9

22.7

e9/l

6.9

6.8

2.12

4307

49064

(3035941) MCH [Entitic mass]

4427

50563

0.44

130.05

53.6

22.6

31.1

30.5

49.07

4355

49792

(3000963) Hemoglobin [Mass/volume] in Blood

4430

50577

0.44

129.64

54.3

22.8

g/l

124.0

137.1

307.65

4359

49799

(3006504) Eosinophils/100 leukocytes in Blood

3094

21548

1.96

129.54

8.8

6.2

2.8

2.9

0.81

2943

20056

(3024731) MCV [Entitic volume]

4429

50565

0.44

129.37

53.6

22.6

93.2

91.4

78.80

4357

49792

(3007461) Platelets [#/volume] in Blood

4429

50547

0.44

128.38

53.9

22.7

e9/l

192.5

242.5

274.46

4319

49200

(3003181) Sodium [Moles/volume] in Urine

334

793

4.41

128.22

1.5

1.3

mmol/l

51.0

63.9

6.02

213

641

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1525

8302

2.14

127.82

1.4

1.2

u/ml

2.5

2.1

0.44

296

2201

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

721

2818

2.78

126.62

13.5

10.0

mmol/l

23.4

24.3

6.18

676

2631

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

229

397

5.97

126.31

1.2

—

(3018418) pH of Serum or Plasma

2212

13864

1.97

125.20

6.1

4.4

7.4

1.83

456

2667

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

176

233

7.76

125.19

1.7

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

418

1191

3.71

124.78

1.7

1.6

—

(3006315) Basophils [#/volume] in Blood

3238

23095

1.93

124.05

8.4

5.9

e9/l

0.0

1.37

2840

19880

(3001604) Monocytes [#/volume] in Blood

3225

22978

1.93

123.88

8.3

5.9

e9/l

0.6

0.12

2822

19756

(3016502) Oxygen saturation in Arterial blood

1134

5550

2.30

123.17

12.1

8.0

95.5

0.06

1099

5345

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

230

411

5.79

122.89

2.4

2.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

949

4311

2.44

122.10

1.8

2.6

g/l

66.0

66.3

0.52

870

3928

(3002030) Lymphocytes/100 leukocytes in Blood

3130

22175

1.91

121.27

9.0

6.3

24.5

27.0

30.34

2974

20583

(3001186) Copper [Moles/volume] in Serum or Plasma

113

13.70

121.18

1.2

umol/l

16.0

16.2

0.09

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

753

3115

2.63

117.81

10.2

7.9

mmol/l

23.4

24.9

16.80

743

3094

(3018010) Neutrophils/100 leukocytes in Blood

3078

21836

1.89

117.15

8.6

6.1

59.1

57.8

7.70

2933

20378

(3013115) Eosinophils [#/volume] in Blood

3292

23865

1.90

117.13

8.8

6.2

e9/l

0.2

5.36

2907

20847

(3019198) Lymphocytes [#/volume] in Blood

3257

23578

1.89

115.85

8.4

6.0

e9/l

1.7

1.9

8.47

2893

20671

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

313

775

4.22

113.58

2.9

u/ml

686.9

2370.2

0.91

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

292

690

4.41

112.62

1.3

—

(3036489) Thrombin time

501

1712

3.11

111.72

3.1

2.2

24.3

21.6

10.22

469

1527

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3842

45672

0.51

111.69

5.3

4.7

mmol/l

4.2

4.5

62.70

3500

42284

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3959

46615

0.50

111.65

5.7

5.2

mmol/l

2.4

2.7

72.68

3592

42905

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3806

45310

0.52

109.23

5.2

4.6

mmol/l

1.3

1.4

39.12

3442

41680

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

177

286

6.36

104.72

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1018

5065

2.23

104.67

12.9

8.5

g/l

112.1

122.5

39.22

989

4890

(3026782) Osmolality of Urine

1620

9651

1.95

102.04

3.4

2.9

mosm/kgh2o

501.4

566.1

26.75

1432

8252

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

20.53

101.28

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

424

1414

3.16

98.25

1.4

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1411

8113

1.98

97.96

2.1

1.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

139

186

7.64

97.90

2.0

1.8

umol/l

132.7

121.5

0.10

105

(3009343) pH of Capillary blood

750

3366

2.41

97.67

5.2

3.7

7.4

0.51

406

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

501

1847

2.88

97.22

2.6

2.4

ug/l

949.3

591.6

0.86

474

1754

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

730

3245

2.43

97.08

5.2

3.6

mmol/l

1.2

1.8

2.50

530

2395

(3013650) Neutrophils [#/volume] in Blood by Automated count

3489

26641

1.80

95.85

11.8

9.4

e9/l

4.1

4.2

1.84

3134

23197

(3024980) IgG subclass 4 [Mass/volume] in Serum

279

719

4.03

95.75

1.7

1.6

g/l

0.9

0.00

220

549

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

754

3421

2.39

95.72

5.3

3.7

kpa

4.9

5.2

10.88

717

3155

(3014007) Fractional oxyhemoglobin in Arterial blood

746

3374

2.39

95.36

14.7

9.8

93.7

93.8

0.35

741

3363

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

217

462

4.84

95.13

1.2

u/l

54.7

64.5

1.19

156

300

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

354

1093

3.39

92.98

2.6

3.7

u/ml

1900.0

803.7

0.29

331

1013

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2707

19433

1.75

89.79

2.5

2.0

pmol/l

90.8

93.6

2.09

1523

10514

(3021960) Folate [Moles/volume] in Serum or Plasma

1733

11071

1.81

84.77

1.9

1.6

nmol/l

18.4

19.9

4.25

1556

9499

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3735

43942

0.56

84.32

4.8

4.2

mmol/l

1.4

1.3

5.87

3365

40128

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

485

1920

2.67

81.69

3.8

3.2

u/ml

0.3

10.26

266

1104

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

646

2933

2.36

81.19

14.6

10.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

387

1368

2.96

80.72

1.5

1.4

ug/g

255.2

262.9

0.25

223

819

(3007853) Bacteria identified in Skin by Aerobe culture

1024

5607

2.01

79.81

2.1

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3579

28425

1.70

76.57

11.2

5.0

mmol/l

7.5

6.8

41.07

3450

26845

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1298

19940

0.55

76.22

3.4

4.3

22.5

21.9

0.64

509

9854

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

142

261

5.55

73.52

1.3

1.2

u/l

147.6

89.9

3.24

132

219

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4387

48978

0.54

73.24

26.3

10.8

u/l

37.6

27.7

48.55

4306

47175

(3034274) Bile acid [Moles/volume] in Serum --fasting

118

182

6.60

73.00

4.5

1.8

umol/l

35.2

12.3

3.78

118

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1003

5623

1.95

72.36

2.0

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

178

405

4.50

71.87

4.1

2.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

136

249

5.57

70.71

1.3

1.2

u/l

38.9

22.1

2.73

125

207

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2876

21859

1.64

70.37

6.6

4.2

—

(3022313) Gas panel - Capillary blood

549

2465

2.36

70.36

5.7

3.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

137

7.49

70.27

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

132

7.62

69.92

1.1

1.0

—

(3026008) Bacteria identified in Urine by Culture

1868

12757

1.69

69.19

3.7

3.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

991

5625

1.92

68.56

2.1

1.8

—

(1761868) Lipid panel - Serum or Plasma

971

15839

0.53

67.57

3.8

3.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3934

45026

0.59

67.06

5.8

4.8

mmol/l

6.7

6.1

71.79

3588

40944

(3004588) Protein electrophoresis panel - Serum or Plasma

706

3591

2.10

66.43

1.6

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1271

7926

1.78

64.53

3.5

3.2

e6/l

2.8

1.5

3.49

739

4463

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

15.42

63.12

1.1

1.2

ml/s/173m2

1.5

0.9

1.93

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

596

2907

2.17

62.31

1.7

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

1939

13652

1.64

62.28

4.2

3.3

e6/l

0.9

0.4

7.21

1566

10397

(3002582) Erythrocytes [#/volume] in Urine

2083

14942

1.62

61.95

4.4

3.4

e6/l

155.5

93.0

0.40

1704

11667

(40758558) Short blood count panel - Blood

1715

11731

1.66

61.60

9.2

6.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

674

3465

2.07

61.37

5.1

4.3

ng/l

102.6

98.0

0.48

596

2993

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

472

2113

2.35

60.62

6.0

3.9

mmol/l

24.1

24.8

4.46

444

1943

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1841

24834

0.62

59.76

4.0

4.9

ug/l

2.9

3.3

0.17

1589

22383

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4239

36237

1.67

58.69

21.1

7.8

u/l

118.7

78.9

186.80

4128

34168

(3036481) Cortisol [Moles/volume] in Serum or Plasma

738

3982

1.98

58.58

2.1

2.3

nmol/l

369.2

368.5

0.02

684

3648

(3000093) Morphology [Interpretation] in Blood Narrative

182

497

3.75

57.43

1.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2065

15015

1.59

56.72

2.7

2.2

u/l

257.4

238.5

0.41

1942

14094

(36304419) Bacteria [Presence] in Urine

1855

13153

1.61

56.63

4.2

3.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

479

2220

2.26

56.60

2.4

2.0

ug/l

2.3

2.5

0.13

432

1964

(3004119) Hemoglobin [Mass/volume] in Venous blood

615

3168

2.06

55.42

5.0

3.6

g/l

116.4

129.8

32.47

601

3093

(3009445) Proteinase 3 Ab [Units/volume] in Serum

466

2161

2.26

54.94

1.3

1.5

u/ml

13.0

17.7

0.29

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

584

2964

2.08

54.76

1.9

1.7

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

339

1368

2.57

54.47

1.6

1.4

iu/ml

6.2

17.0

1.30

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

876

5116

1.84

54.35

4.8

3.5

—

(3019060) Gas panel - Arterial blood

670

3596

1.98

53.74

6.8

5.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

125

272

4.68

53.35

1.8

1.6

u/l

12.2

6.1

1.10

122

(4198724)

134

6.50

52.71

4.3

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

916

14383

0.57

52.42

2.5

3.0

ug/l

0.7

0.8

0.30

625

9682

(3009508) Creatinine [Moles/volume] in Urine

2144

15942

1.55

52.22

3.9

3.2

mmol/l

6.9

7.9

22.41

1793

13373

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2311

17536

1.54

50.96

3.2

2.2

nmol/l

69.6

77.4

28.95

2122

15648

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

382

1682

2.36

50.75

1.6

1.5

titre

103.6

276.1

1.67

(1616796) Gas panel - Central venous blood

297

1163

2.64

50.70

4.1

4.0

—

(3000850) Epithelial cells [#/volume] in Urine

1510

10429

1.61

50.20

3.3

2.7

e6/l

6.3

4.1

7.26

1358

9152

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

275

1041

2.73

50.19

1.2

1.6

nmol/l

0.9

0.8

1.09

214

867

(40761511) CBC panel - Blood by Automated count

4275

47276

0.62

50.08

35.0

14.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1278

8474

1.66

50.06

3.4

2.9

e6/l

1.4

1.0

2.36

744

4968

(3018095) Leukocytes [#/volume] in Urine

2232

16879

1.53

49.60

5.0

3.9

e6/l

105.2

89.6

0.32

1740

12450

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

268

1024

2.70

48.02

1.8

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

412

1928

2.23

47.35

1.8

u/l

48.5

38.4

9.60

369

1685

(3024928) Oxygen saturation in Venous blood

283

1129

2.59

46.49

3.8

3.6

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

7.11

46.10

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

180

569

3.23

45.32

5.2

3.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

14.23

45.04

1.3

1.5

mg/l

41.0

42.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

204

697

3.00

45.00

4.0

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

489

2498

2.05

44.73

5.5

3.6

mmol/l

24.3

25.2

4.83

471

2421

(3023103) Potassium [Moles/volume] in Serum or Plasma

4408

48176

0.62

44.47

45.3

18.3

mmol/l

4.0

5.12

4325

46972

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

286

1176

2.51

44.09

1.6

1.5

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

469

2372

2.07

44.07

4.2

3.0

0.7

0.16

455

2272

(3012441) Differential panel - Pleural fluid

182

590

3.15

43.95

1.8

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2129

16234

1.50

43.93

4.6

4.0

mg/mmol

16.5

9.4

5.74

1448

10655

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

368

1697

2.25

43.77

1.5

3.4

mg/l

51.5

56.5

0.23

290

1378

(3012501) Base excess in Blood by calculation

283

1163

2.51

43.68

5.4

4.7

mmol/l

2.4

2.5

0.42

182

805

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

211

747

2.89

43.67

7.1

6.9

mg/l

12.2

11.9

0.38

188

686

(3013290) Carbon dioxide [Partial pressure] in Blood

283

1164

2.51

43.60

5.5

4.7

kpa

4.7

5.0

8.98

273

1143

(36660697) Celiac disease serology panel - Serum

555

3001

1.94

43.13

1.2

—

(3027315) Oxygen [Partial pressure] in Blood

283

1172

2.49

42.97

5.5

4.7

kpa

8.6

8.5

0.30

273

1150

(3034860) Kappa light chains.free [Mass/volume] in Serum

366

1698

2.23

42.89

1.6

3.4

mg/l

78.4

92.8

0.16

288

1376

(3010421) pH of Blood

312

1356

2.38

42.60

5.4

4.6

7.4

0.08

274

1144

(4035726)

710

4175

1.80

42.33

1.7

1.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

212

766

2.84

42.25

1.8

1.5

g/l

27.8

33.1

5.79

191

688

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

358

1656

2.24

42.24

1.5

3.4

ratio

1.7

3.2

0.72

117

(21494755) Public health laboratory ask at order entry panel

100

3550

0.27

42.14

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4406

48038

0.63

41.54

45.2

18.1

mmol/l

138.0

139.7

212.82

4324

46897

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3904

43621

0.67

40.97

33.9

14.6

ml/min/173m2

78.6

78.5

0.13

3450

36352

(3016038) Potassium [Moles/volume] in Urine

119

306

3.95

40.93

1.1

1.2

mmol/l

32.0

34.1

0.41

264

(3028626) Oxygen [Partial pressure] in Capillary blood

288

1232

2.41

40.73

4.5

3.1

kpa

8.2

8.0

0.86

274

1130

(3003338) MCHC [Mass/volume]

3315

38193

0.68

40.64

48.2

19.9

g/l

332.3

333.1

3.61

3275

37891

(3016879) Cocaine [Presence] in Urine

223

845

2.71

40.59

4.1

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

317

1435

2.28

39.36

5.1

3.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1383

9860

1.53

38.22

2.3

1.8

mg/l

2.4

1.2

12.50

1184

7684

(40760888) Immunoglobulin light chains.free panel - Serum

290

1280

2.33

38.20

1.5

3.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

123

5.75

38.08

1.4

1.5

ug/l

12.8

8.7

4.55

123

(3037756) Immunofixation for Serum or Plasma

266

1133

2.41

37.97

1.2

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

679

4071

1.76

37.64

5.0

4.2

0.9

1.0

0.38

264

1238

(3012516) Albumin [Mass/volume] in Urine

2005

15451

1.46

37.61

3.7

3.3

mg/l

412.0

382.4

0.11

1397

10163

(3028308) Erythrocytes [#/volume] in Pleural fluid

175

608

2.94

37.49

1.8

1.4

e6/l

37596.4

68587.5

0.96

105

361

(3008295) Osmolality of Serum or Plasma

149

475

3.19

37.03

1.3

mosm/kgh2o

276.4

279.6

0.65

120

369

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

381

1902

2.08

36.94

1.5

2.3

g/l

13.2

10.2

15.52

320

1614

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

2036

2.04

36.78

1.5

2.3

g/l

7.1

7.4

2.70

295

1520

(3023199) Leukocytes [#/volume] in Pleural fluid

187

681

2.81

36.74

1.8

1.5

e6/l

10752.5

1927.6

0.81

132

490

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

9.23

36.52

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

399

2035

2.03

36.48

1.5

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

225

904

2.55

36.40

4.1

2.1

—

(3028300) Cannabinoids [Presence] in Urine

226

911

2.54

36.32

4.3

2.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

398

2033

2.03

36.24

1.5

2.3

g/l

4.5

3.8

10.14

290

1461

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1397

10078

1.51

36.20

1.8

1.7

pmol/l

527.3

28012359.5

6.61

1140

8375

(3027008) Opiates [Presence] in Urine

224

909

2.52

35.49

3.1

2.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

249

4.03

35.14

2.1

1.9

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

249

1069

2.39

34.92

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

249

1069

2.39

34.92

1.5

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

319

1521

2.16

34.84

1.5

2.2

g/l

0.0

0.34

281

1392

(3026493) Urate [Moles/volume] in Serum or Plasma

1778

13543

1.46

34.80

4.0

2.8

umol/l

2205.1

4805.4

2.68

1551

11748

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

14.84

34.79

3.1

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

127

3604

0.34

34.75

1.6

1.9

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

373

1891

2.04

34.65

1.5

2.3

g/l

3.1

0.65

297

1488

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

111

306

3.68

34.62

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

303

1422

2.19

34.44

1.5

2.2

g/l

0.0

0.41

265

1297

(3045788) Cell count panel - Pleural fluid

153

519

3.00

34.22

1.8

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

617

3696

1.75

34.14

4.8

4.0

0.6

0.7

0.19

188

886

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

109

300

3.68

34.08

1.4

1.5

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

431

2313

1.93

34.02

6.0

4.2

50.1

49.0

0.38

423

2283

(3015235) Bicarbonate [Moles/volume] in Capillary blood

299

1405

2.19

33.87

3.8

3.2

mmol/l

23.3

24.8

4.73

267

1213

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

322

1559

2.13

33.81

1.5

2.1

g/l

34.9

37.5

9.11

275

1351

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

408

2158

1.96

33.60

7.5

5.5

2.0

1.7

4.77

382

2021

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

297

1399

2.18

33.44

1.5

2.2

g/l

0.0

0.00

263

1295

(3021589) Normoblasts [#/volume] in Blood

2502

20390

1.41

33.17

17.5

10.1

e9/l

0.0

0.26

2061

16709

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

6.72

33.08

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

214

4.16

32.70

1.5

7.1

mg/l

55.0

1162.8

0.50

152

(3000494) Fungus identified in Specimen by Culture

851

5606

1.61

32.69

1.9

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

241

3.95

32.52

1.7

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

241

3.95

32.52

1.7

1.6

—

(3027944) Amphetamines [Presence] in Urine

215

892

2.47

32.51

3.9

2.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1897

14783

1.42

32.21

3.6

3.1

ng/l

2039.8

1560.6

2.98

1676

12759

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

138

458

3.06

32.08

1.6

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

341

1727

2.04

31.73

1.6

2.4

g/l

0.5

1.0

1.99

288

1488

(40768806) Pleura Pathology biopsy report

163

607

2.74

30.73

1.7

1.6

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

563

3389

1.73

30.48

11.1

7.3

mmol/l

23.5

24.5

5.94

530

3173

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3941

43322

0.71

29.79

9.2

6.1

mmol/mol

42.6

40.5

20.49

3665

40038

(3029075) Extractable nuclear Ab panel - Serum

120

5.13

29.40

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

139

491

2.88

28.95

1.4

1.3

nmol/l

1.4

1.5

0.17

129

437

(3031040) Bacteria [#/volume] in Urine by Automated count

3412

29647

1.38

28.94

5.7

4.4

e6/l

1710.6

1450.4

0.07

475

(40767503) Oxygen content in Capillary blood by calculation

243

1119

2.22

28.93

3.6

2.6

15.0

16.2

4.10

124

589

(3007930) Methemoglobin/Hemoglobin.total in Blood

390

2135

1.89

28.90

7.6

5.5

0.9

0.06

368

2003

(3036782) Glucose [Moles/volume] in Pleural fluid

145

526

2.80

28.75

1.5

1.4

mmol/l

6.8

6.3

0.99

138

485

(3021440) Promyelocytes/100 leukocytes in Blood

614

3852

1.67

28.43

5.2

4.2

0.1

1.22

241

1150

(3021901) Oxygen saturation in Capillary blood

223

1000

2.28

28.30

3.4

2.9

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

220

983

2.29

28.16

1.2

titre

50.0

246.7

—

(3037121) Protein [Mass/volume] in Urine

323

1675

1.98

28.10

2.9

3.4

g/l

0.3

0.35

180

769

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1311

9755

1.45

27.89

4.7

3.9

ng/l

355.8

622.0

1.25

1111

8054

(3018405) Lactate [Moles/volume] in Arterial blood

353

1896

1.92

27.71

6.2

4.2

mmol/l

1.9

1.4

6.80

344

1869

(3027923) C peptide [Moles/volume] in Serum or Plasma

262

3.55

27.41

1.3

nmol/l

1.2

1.1

0.16

201

(3051651) Icteric interference index of Serum or Plasma

297

3.37

27.22

4.1

3.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

145

544

2.71

26.98

1.5

1.3

u/l

807.1

343.5

0.66

135

519

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2288

0.28

26.37

1.3

1.5

—

(3025159) Blasts/100 leukocytes in Blood

574

3618

1.65

26.00

5.1

4.2

0.3

0.2

0.20

203

966

(3022806) Fractional oxyhemoglobin in Capillary blood

164

667

2.50

25.92

2.6

1.9

89.2

89.5

0.22

164

661

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

236

3.55

24.82

1.1

u/l

118.8

93.1

1.02

184

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

237

3.54

24.66

1.1

u/l

47.1

28.8

0.94

177

(3004809) Band form neutrophils/100 leukocytes in Blood

194

872

2.27

24.51

3.7

1.3

1.5

0.61

150

660

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.40

24.40

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

232

3.53

23.97

1.4

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

232

3.53

23.97

1.4

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

450

2.75

23.50

1.3

1.4

g/l

9.7

6.8

3.69

316

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

248

1256

2.02

23.07

1.4

1.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

596

3901

1.59

23.04

5.4

4.2

mmol/l

1.2

9.51

561

3440

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

212

1017

2.13

22.81

1.5

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

291

3.16

22.63

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

291

3.16

22.63

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

292

3.15

22.50

1.1

—

(3019225) pH of Specimen

694

4727

1.53

22.47

6.5

4.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

334

1884

1.82

22.45

2.6

2.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

120

450

2.70

22.41

1.3

1.4

g/l

0.5

0.4

1.50

316

(3028192) IgG subclass 2 [Mass/volume] in Serum

120

450

2.70

22.41

1.3

1.4

g/l

3.2

3.0

0.50

316

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

115

422

2.76

22.39

1.4

1.3

u/l

15.7

13.3

0.23

106

387

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

175

783

2.27

22.38

1.1

1.3

miu/ml

218.6

190.9

0.28

292

(3008757) Leukocyte morphology finding [Identifier] in Blood

137

550

2.53

22.30

3.9

4.4

—

(4062490)

120

453

2.68

22.12

1.3

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

295

3.12

22.12

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

295

3.12

22.12

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

295

3.12

22.12

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

126

489

2.61

21.99

4.2

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

170

759

2.28

21.86

1.1

iu/ml

132.4

88.1

0.21

163

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

245

1268

1.97

21.45

1.4

1.5

g/l

0.2

4.35

229

1202

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

128

509

2.55

21.27

3.2

3.0

—

(3020891) Body temperature

363

2134

1.75

21.21

7.7

5.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

652

4435

1.53

21.18

3.7

2.9

ng/l

267.2

214.4

2.17

606

4039

(3014148) Varicella zoster virus Ab [Titer] in Serum

112

421

2.69

20.84

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

249

1311

1.94

20.74

1.4

1.5

g/l

1.1

1.2

2.88

235

1244

(3008116) Ketones [Moles/volume] in Urine by Test strip

102

4.64

20.27

1.6

1.4

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

243

3.20

19.62

1.5

1.3

u/l

285.0

397.5

0.50

223

(3009542) Hematocrit [Volume Fraction] of Blood

3765

40956

0.76

19.60

40.1

16.6

36.2

40.0

96.15

2445

28378

(3042111) Morphology [Interpretation] in Bone marrow Narrative

188

920

2.08

19.24

1.6

—

(3044889) 12 lead EKG panel

3023

33783

0.78

19.09

4.5

4.0

—

(3047181) Lactate [Moles/volume] in Blood

291

1656

1.80

19.00

8.7

6.5

mmol/l

1.9

1.3

5.71

248

1468

(3022145) Colonoscopy Study observation

740

5290

1.46

18.71

1.5

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1864

15451

1.31

18.63

3.9

3.6

mmol/l

2.3

16.88

1617

13483

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

347

2098

1.70

18.31

2.2

2.0

—

(3025941) Bacteria identified in Stool by Culture

379

2350

1.66

18.17

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

115

474

2.46

17.78

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

322

1925

1.71

17.71

2.0

1.8

—

(3035880) pH of Pleural fluid

319

2.79

17.62

1.4

1.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2219

18921

1.28

17.56

5.4

3.8

ng/l

42.0

88.6

1.18

1833

13879

(40762365) Oxygen content in Arterial blood by calculation

4.41

17.50

2.9

3.5

ml/dl

13.7

14.8

1.27

(3001893) Eosinophils/100 leukocytes in Pleural fluid

181

3.40

17.20

1.6

1.5

2.7

2.6

0.03

155

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

135

608

2.25

17.08

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

203

3.23

16.90

1.0

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1236

9782

1.34

16.86

6.5

4.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

265

1526

1.77

16.65

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

209

1120

1.90

16.56

1.3

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

132

600

2.23

16.35

1.5

—

(3044927) Protein electrophoresis panel - Urine

118

512

2.33

16.31

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

229

1272

1.83

16.22

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

131

598

2.22

16.07

1.5

—

(21494434) Karyotype in Bone marrow

111

475

2.36

15.84

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.44

15.62

2.0

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

129

594

2.20

15.50

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

129

594

2.20

15.50

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

129

596

2.19

15.38

1.4

1.5

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

38.14

15.37

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

120

540

2.25

15.26

3.9

3.7

62.9

57.9

1.39

337

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

192

3.15

15.03

3.0

1.9

u/ml

41870.1

2348.2

0.52

(3043409) Potassium [Moles/volume] in Arterial blood

272

1625

1.71

15.02

7.1

4.4

mmol/l

3.9

0.02

255

1521

(3039443) Prostate specific Ag panel - Serum or Plasma

1429

0.32

15.01

1.4

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

143

3.52

14.95

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

240

1388

1.76

14.88

2.4

2.3

ug/min

188.0

115.2

1.05

133

861

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

226

2.94

14.72

1.6

1.5

57.3

64.9

0.92

184

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

570

4052

1.45

14.69

3.7

2.7

ml/min/173m2

57.0

64.7

3.37

243

1623

(3045716) Anion gap in Serum or Plasma

233

2.90

14.54

3.0

2.3

mmol/l

8.7

9.4

0.73

181

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

164

847

1.96

14.54

1.1

1.2

u/ml

1.9

5.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

217

1229

1.80

14.45

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

176

938

1.90

14.23

1.6

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3796

40754

0.79

14.15

4.8

4.4

mu/l

2.2

2.3

0.06

3452

36940

(3018572) Chloride [Moles/volume] in Blood

211

1200

1.79

13.87

10.2

7.4

mmol/l

104.2

105.2

1.46

191

1079

(3039000) Anion gap in Blood

211

1200

1.79

13.87

10.2

7.4

mmol/l

12.6

11.3

4.21

191

1079

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.86

13.77

1.1

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

138

3.43

13.54

1.7

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

249

1499

1.69

13.40

1.2

u/ml

0.4

1.0

1.55

142

(3037467) Urinalysis macro (dipstick) panel - Urine

3426

31347

1.23

12.85

5.5

4.3

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

182

1023

1.80

12.48

1.2

u/ml

21.4

6.2

0.58

102

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

193

1104

1.77

12.48

1.2

u/ml

37.7

30.3

0.17

(3000919) Neutrophils/100 leukocytes in Pleural fluid

161

3.12

12.45

1.5

1.4

27.0

22.3

0.45

148

(3042631) Mycobacterium sp identified in Specimen

144

753

1.94

12.37

2.3

2.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

172

955

1.83

12.28

2.9

3.0

nmol/l

0.8

0.09

113

716

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1061

8552

1.30

12.21

3.7

3.2

mmol/l

2.5

11.26

882

7492

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.81

12.15

1.6

13.3

7.9

0.65

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2244

25261

0.82

12.13

2.8

2.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4352

45786

0.79

12.08

37.4

15.6

mg/l

23.7

26.1

7.49

4102

36815

(3006184) Hemoglobin [Mass/volume] in Capillary blood

199

1163

1.74

11.96

3.0

2.2

g/l

119.6

130.1

6.43

161

834

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

182

1037

1.78

11.94

1.2

u/ml

8.3

7.8

0.03

169

(3013945) Hepatitis B virus e Ab [Presence] in Serum

7.41

11.83

1.3

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

219

2.71

11.43

2.5

2.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

175

2.93

11.42

2.6

3.9

54.2

52.8

0.19

169

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

164

2815

0.57

11.42

1.3

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.64

11.41

1.3

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.52

11.40

1.0

1.3

u/l

18.8

20.1

0.11

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.70

11.37

8.8

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

140

747

1.90

11.36

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

143

773

1.87

11.15

1.2

u/ml

64.6

47.3

0.37

(3002385) Erythrocyte distribution width [Ratio]

3478

37362

0.82

11.10

45.8

18.8

15.1

13.8

240.36

3433

36516

(21494890) Protein electrophoresis panel - 24 hour Urine

114

575

2.00

10.91

1.3

2.1

—

(3014271) Vancomycin [Susceptibility]

260

2.52

10.87

3.5

2.9

—

(3042517) Benzodiazepines panel - Urine

6.97

10.56

2.5

2.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1606

0.46

10.53

1.4

1.7

—

(1002224) Polysomnography panel

1844

0.50

10.26

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

11.02

10.16

1.1

1.4

mmol/l

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

198

1211

1.66

10.11

2.0

1.9

mg/l

13.0

11.4

1.28

185

1125

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

160

2.89

10.09

1.5

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.83

9.92

1.5

1.4

28.0

25.5

0.12

(3040151) Glucose [Moles/volume] in Capillary blood

110

571

1.94

9.75

66.9

7.5

mmol/l

8.1

7.4

1.02

483

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

3.67

9.68

2.1

2.5

mg/l

20.7

76.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

429

2.09

9.68

1.3

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

194

1197

1.64

9.59

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

192

1186

1.64

9.46

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

114

607

1.90

9.38

1.6

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

193

1206

1.62

9.09

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

330

4615

0.70

9.07

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

416

2.06

8.92

1.4

iu/ml

26.8

25.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

163

985

1.67

8.77

1.1

u/ml

7.8

6.9

0.06

117

(40768446) Kidney Pathology biopsy report

203

2.53

8.69

1.4

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

153

2.76

8.52

2.0

2.1

ug/l

83.0

58.6

0.76

148

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

3.56

8.38

1.2

72.1

77.6

0.21

(3052592) Norovirus Ag [Presence] in Stool

3.31

8.32

1.5

—

(4146454)

106

576

1.86

8.25

2.8

2.7

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

107

3.10

8.23

1.2

1.1

74.1

85.9

1.25

(3043410) Blood group antigens tested for on Red Blood Cells

129

2.88

8.15

2.3

1.9

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

317

2.16

8.13

1.5

umol/l

14.6

13.8

0.35

299

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

248

2.31

8.04

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

111

620

1.81

7.92

3.7

2.4

—

(3011648) Oxygen content in Venous blood

422

1.98

7.89

2.1

3.0

9.3

11.2

3.31

422

(3020123) Porphyrins [Interpretation] in Serum or Plasma

5.85

7.85

1.4

1.0

—

(3004775) Volume in Urine collected for unspecified duration

466

1.92

7.78

2.1

2.2

747.2

634.6

1.16

313

(4094501)

1472

0.52

7.63

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

170

2.54

7.48

1.3

ug/l

6.7

326.0

1.22

(3044242) Glucose [Moles/volume] in Arterial blood

269

2.21

7.48

2.9

2.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

3.34

7.37

1.2

63.4

77.5

1.12

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

149

925

1.63

7.29

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

110

2.92

7.26

2.1

2.0

—

(3006576) Bicarbonate [Moles/volume] in Blood

203

2.38

7.25

5.0

7.4

mmol/l

23.9

25.0

0.74

185

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.06

7.14

1.6

1.5

ug/l

0.3

0.4

0.25

(3020876) Protein [Mass/time] in 24 hour Urine

474

1.87

7.10

1.7

2.0

g/24h

0.8

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.26

7.09

11.0

13.3

mmol/l

5.0

5.8

1.05

(3048879) Bone marrow aspiration report

163

2.53

7.07

1.2

1.7

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

107

2.91

6.99

1.2

1.3

66.7

83.9

1.86

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

317

2.06

6.97

1.3

1.2

mmol/l

13.7

11.6

1.40

110

(3035947) Staphylolysin Ab [Units/volume] in Serum

245

2.22

6.95

1.2

1.1

iu/ml

3.1

3.6

—

(3017704) Immunofixation for Urine

291

2.11

6.93

1.3

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3594

33892

1.16

6.86

5.8

4.1

mm/h

22.2

12.5

131.54

3330

31303

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1407

0.54

6.81

1.7

mg/l

5.8

3.9

1.28

997

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

539

1.79

6.80

4.3

3.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

820

1.64

6.72

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

922

1.60

6.69

1.3

u/l

43.7

40.8

0.12

135

798

(40761536) Microorganisms panel - Urine sediment

480

3764

1.30

6.66

5.0

4.0

—

(44790048)

101

580

1.75

6.64

1.8

1.5

—

(44790049)

101

580

1.75

6.64

1.8

1.5

—

(44806118)

101

580

1.75

6.64

1.8

1.5

—

(44790047)

101

580

1.75

6.64

1.8

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

238

2.20

6.58

1.2

1.5

—

(3000012) Reticulocyte production index

271

2.11

6.56

2.2

1.5

—

(3045142) Bone marrow Pathology biopsy report

104

605

1.73

6.54

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

111

658

1.70

6.52

1.4

1.2

u/ml

3.4

4.4

0.54

289

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

438

1.86

6.49

1.4

1.6

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

259

2.13

6.49

3.8

3.7

—

(3020491) Glucose [Moles/volume] in Blood

347

1.97

6.47

2.5

2.0

mmol/l

8.7

6.9

2.39

231

(3017446) Testosterone [Moles/volume] in Serum or Plasma

385

4975

0.76

6.37

2.0

2.2

nmol/l

13.2

13.0

0.18

331

4385

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

102

2.85

6.35

2.8

4.2

u/l

101.6

65.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

588

4760

1.26

6.33

2.7

2.4

ug/l

8.5

8.1

0.13

514

4211

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

122

751

1.64

6.23

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

251

2.12

6.18

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

521

1.76

6.08

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.59

6.03

2.2

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.59

6.03

2.3

2.1

—

(3019977) pH of Arterial blood

308

1.99

6.01

4.1

2.4

7.4

0.22

110

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

275

2.05

5.95

2.0

ug/min

144.8

216.2

0.30

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

273

3670

0.73

5.93

1.5

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

4.18

5.81

1.1

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

127

806

1.59

5.76

1.2

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1206

10578

1.18

5.74

3.9

3.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

201

1408

1.44

5.72

2.7

3.8

u/ml

143.5

67.5

2.81

192

1357

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

356

1.89

5.71

1.3

1.5

u/ml

25.9

26.5

0.03

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

117

732

1.61

5.64

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

329

2508

1.33

5.62

2.5

2.4

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

12.87

5.57

1.0

1.4

umol/l

1181.1

2718.6

—

(3016750) Collection duration of Urine

331

1.91

5.56

2.0

min

484.9

488.0

0.08

244

(3035637) Corticotropin [Mass/volume] in Plasma

581

1.68

5.55

1.4

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

560

1.69

5.49

1.7

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.47

5.44

1.8

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1104

12559

0.85

5.44

1.9

1.7

mmol/l

1.5

1.4

2.31

959

10486

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

524

1.71

5.43

1.7

1.8

—

(40768800) Prostate Pathology biopsy report

1575

0.62

5.42

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

109

678

1.62

5.40

1.4

1.2

u/ml

2.7

3.3

0.30

214

(3025315) Body weight

3.73

5.36

5.6

4.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3102

32820

0.88

5.35

3.8

3.6

pmol/l

14.6

14.9

6.11

2781

29606

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

161

2.31

5.33

1.1

miu/ml

1735.6

1553.9

0.59

161

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.79

5.29

1.4

1.3

mmol/l

0.4

1.8

1.33

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

316

1.91

5.28

2.2

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

282

1.96

5.24

2.1

umol/l

25.1

38.3

—

(3030703) Everolimus [Mass/volume] in Blood

+∞

5.21

13.6

0.0

ug/l

5.4

—

(40768443) Skin Pathology biopsy report

276

2075

1.35

5.20

1.3

1.2

—

(3017569) Oxygen content in Arterial blood

263

1.99

5.15

3.2

2.2

—

(3048689) Calprotectin [Mass/mass] in Stool

569

4705

1.23

5.08

2.7

2.3

ug/g

186.8

154.8

1.15

473

3759

(3038177) Helicobacter pylori Ab [Presence] in Serum

104

651

1.61

5.05

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

180

2.17

4.92

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

247

1.99

4.92

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

457

1.72

4.88

1.6

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

457

1.72

4.88

1.6

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

457

1.72

4.88

1.6

1.8

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

362

1.80

4.84

1.2

mmol/l

2.5

2.1

1.02

337

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

2.34

4.81

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

270

1.93

4.81

1.6

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

270

1.93

4.81

1.6

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

270

1.93

4.81

1.6

2.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

270

1.93

4.81

1.6

2.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

107

2.53

4.78

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

133

898

1.49

4.64

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

122

810

1.52

4.61

4.4

3.6

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

8.19

4.56

1.0

u/field

1.0

1.5

—

(3018291) Platelet Ab [Presence] in Serum

8.19

4.56

1.1

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

248

1.94

4.52

1.1

1.3

—

(3023383) Lactate [Moles/volume] in Pleural fluid

181

2.11

4.46

1.6

1.3

mmol/l

3.6

3.4

0.12

164

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

182

2.10

4.41

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

360

1.76

4.35

1.3

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

245

1.93

4.33

1.1

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1362

12286

1.14

4.32

1.5

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

184

1343

1.38

4.25

1.7

1.6

iu/ml

0.5

11.2

1.13

291

(3026389) Candida sp identified in Specimen by Organism specific culture

532

1.61

4.19

1.5

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

403

1.70

4.15

1.3

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

134

2.25

4.14

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

615

1.55

4.08

1.3

1.2

88.8

115.1

9.19

556

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

476

1.63

4.01

1.3

1.2

90.7

97.1

1.20

443

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

126

871

1.46

3.97

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

211

1.95

3.95

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

211

1.95

3.95

1.7

2.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.43

3.90

1.1

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

2.89

3.89

1.2

2.1

mmol/l

0.5

1.3

—

(4306422)

631

1.53

3.87

1.4

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

353

1.71

3.79

2.1

2.4

e6/l

587.2

611.2

0.09

150

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1315

0.66

3.76

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

581

1.54

3.71

2.6

2.1

mg/l

17.3

24.0

1.05

141

(21494815) CD4 cells/100 lymphocytes in Specimen

405

1.64

3.58

1.9

2.2

38.4

42.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

138

997

1.39

3.46

1.2

1.3

mmol/l

4.2

3.9

2.10

124

931

(3004716) Salmonella sp identified in Stool by Organism specific culture

226

1760

1.30

3.44

1.3

—

(3036603) Volume of Urine

319

1.70

3.40

1.6

1.7

1603.3

1919.3

0.58

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

419

1.61

3.39

1.8

2.2

u/l

3644.8

2575.6

0.11

153

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

209

1.87

3.38

1.7

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

209

1.87

3.38

1.7

2.3

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

290

1.73

3.36

2.9

2.7

42.4

36.5

0.96

102

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

184

1401

1.32

3.31

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

108

2.23

3.31

2.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

153

1135

1.36

3.28

1.3

mg/l

536.7

552.4

0.11

145

1071

(3013512) EKG study

1556

14364

1.11

3.26

5.3

4.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

1.97

3.23

4.3

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

163

1.97

3.23

4.3

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

204

0.29

3.19

1.2

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

637

1.47

3.15

1.2

1.1

—

(3002256) Pathology report gross observation

696

6121

1.16

3.14

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

132

2.05

3.06

1.2

1.1

—

(40757373) Influenza virus identified in Isolate

106

2.17

3.02

1.6

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

477

0.50

2.99

1.3

1.4

pmol/l

59.3

126.4

0.49

145

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

148

1.96

2.94

1.7

1.4

20.4

24.9

0.33

119

(3041918) Cholesterol [Moles/volume] in Pleural fluid

114

2.11

2.93

1.5

1.2

mmol/l

1.2

1.7

2.37

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

319

1.64

2.89

1.8

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

305

1.65

2.85

1.6

2.5

e9/l

0.2

1.31

267

(1761482) Bacteria [#/volume] in Urine by Culture

165

1270

1.31

2.81

5.4

4.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.65

2.79

1.4

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

2.47

2.78

1.8

1.4

76.3

71.8

—

(3023410) Appearance of Cerebral spinal fluid

442

1.52

2.76

1.4

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

2332

22109

1.09

2.75

4.4

3.6

estimate

0.0

0.50

497

4073

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

316

1.62

2.74

1.3

1.6

—

(3049242) von Willebrand panel - Platelet poor plasma

6.01

2.69

1.5

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

132

1.97

2.69

2.1

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

319

1.60

2.65

1.6

2.4

e6/l

362.0

508.5

1.78

269

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

780

0.64

2.62

1.5

1.4

—

(3011412) CD3 cells [#/volume] in Blood

464

1.49

2.62

1.7

2.3

e9/l

0.6

1.1

6.74

272

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.55

2.61

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

345

1.57

2.58

1.1

1.2

u/ml

98.2

34.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

338

1.57

2.56

1.3

1.4

u/l

25.1

28.1

0.22

277

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

135

1.93

2.54

1.3

nmol/l

225.4

139.7

0.42

102

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

128

1.96

2.54

4.8

5.9

36.6

74.9

2.86

102

(3004347) Hepatitis D virus Ab [Presence] in Serum

5.46

2.54

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.60

2.53

1.1

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

131

993

1.33

2.52

1.3

1.4

e6/l

18.9

21.4

0.10

100

765

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

131

993

1.33

2.52

1.4

1.5

e6/l

687.3

1266.8

0.63

105

808

(3030981) Hyaline casts [#/volume] in Urine by Automated count

328

2767

1.20

2.51

3.4

2.9

e6/l

0.5

0.3

1.20

322

2713

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

144

1854

0.77

2.48

1.1

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

180

1.78

2.46

1.1

1.2

—

(3004451) EKG impression Narrative

271

1.63

2.46

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

255

0.39

2.44

6.3

6.5

—

(3044941) Cell count panel - Synovial fluid

107

793

1.36

2.40

1.5

1.4

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.34

2.39

1.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

197

1.73

2.38

1.4

1.5

—

(4010399)

390

3357

1.17

2.38

1.4

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.12

2.36

1.1

1.3

—

(3006270) Folate [Moles/volume] in Blood

402

1.50

2.35

1.2

nmol/l

296.0

355.4

1.60

334

(4268621)

451

1.47

2.35

2.6

2.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

603

1.40

2.30

1.6

pmol/l

164.8

221.6

0.64

593

(3036670) Protein [Mass/volume] in Synovial fluid

155

1.81

2.29

1.5

1.2

g/l

38.3

39.5

0.13

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

316

1.56

2.29

1.3

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

430

1.47

2.27

1.8

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.89

2.25

1.1

1.2

nmol/l

258.4

256.6

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.28

2.24

2.0

2.2

—

(3017509) Phencyclidine [Presence] in Urine

3.11

2.22

2.0

1.4

—

(4212803)

2.41

2.19

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

635

1.38

2.18

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.13

2.18

1.7

1.3

u/l

36.3

433.1

0.56

(3047189) Immunofixation for 24 hour Urine

273

1.58

2.16

1.1

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

685

1.35

2.06

4.2

5.0

umol/l

343.7

355.5

0.31

591

(3000475) Leukocytes [#/volume] in Synovial fluid

154

1230

1.26

2.05

1.6

e6/l

18872.8

15717.5

0.34

101

873

(3011325) HIV 1+2 Ab [Presence] in Serum

3.50

2.05

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.50

2.05

1.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.18

2.04

1.1

—

(3021788) Differential panel - Synovial fluid

118

913

1.30

2.03

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

475

1.42

2.01

1.2

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.08

2.01

5.5

4.7

—

(3002619) Bacteria identified in Specimen by Culture

2.05

2.00

1.5

1.2

—

(3023419) Bacteria identified in Sputum by Culture

672

1.34

1.99

3.5

2.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

478

1.41

1.95

1.3

e6/l

271451.5

129173.8

0.62

333

(44806420)

149

1.75

1.94

2.7

2.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.75

1.93

1.0

1.3

—

(3000492) Spirometry study

497

4432

1.13

1.90

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.86

1.86

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

100

1.90

1.85

1.9

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

1.85

0.0

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

1.85

0.0

5.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

510

5684

0.89

1.84

1.3

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

135

1078

1.26

1.84

1.4

u/l

10.7

8.2

1.02

872

(3020393) Adenovirus Ag [Presence] in Stool

2.50

1.83

1.3

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.17

1.82

1.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

2307

22131

1.07

1.81

5.9

4.8

estimate

0.0

0.50

508

4166

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

352

1.45

1.80

1.3

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.96

1.79

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.50

1.73

1.8

3.2

—

(4133840)

138

0.36

1.73

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

385

0.60

1.72

1.0

ng/l

671.3

728.1

0.28

260

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.67

1.72

2.4

2.6

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

339

1.45

1.72

2.2

2.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

3.85

1.71

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.70

0.0

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.29

1.70

1.0

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

118

1.78

1.69

1.5

1.2

pmol/l

320.9

268.4

0.30

(3019897) Erythrocyte distribution width [Ratio] by Automated count

444

0.63

1.69

5.2

3.1

13.7

13.2

0.89

438

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.80

1.65

1.3

1.7

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

197

1.58

1.62

4.0

2.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

131

0.38

1.62

2.0

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

0.48

1.61

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.15

1.61

1.0

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

2327

22398

1.07

1.60

4.4

3.6

estimate

0.0

1.98

463

3974

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

238

1.52

1.59

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.20

1.56

1.7

2.5

u/field

0.4

0.3

0.04

(37021550) Renin [Units/volume] in Plasma --upright

114

1.76

1.56

1.3

mu/l

105.2

61.6

0.62

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

355

1.41

1.55

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.88

1.54

1.8

1.7

ng/l

87.9

160.1

2.08

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

128

0.39

1.48

2.2

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

109

1.75

1.46

2.4

2.1

e6/l

110.9

386.3

0.67

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

353

0.62

1.43

3.4

5.2

u/ml

64.7

45.7

—

101

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

188

1.55

1.42

1.2

1.1

iu/ml

309.8

199.9

0.72

188

(3025577) Chromium [Mass/volume] in Blood

363

0.63

1.40

1.8

2.1

ug/l

5.6

2.2

0.41

309

(40765096) Chromosome analysis panel by Banding

173

1.56

1.39

1.1

—

(3010503) CD19 cells [#/volume] in Blood

313

1.41

1.38

1.4

2.3

e9/l

0.1

0.2

1.25

302

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

564

1.30

1.36

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

1.34

0.0

2.0

—

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.97

1.32

1.1

2.2

umol/l

15.8

19.7

0.58

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1642

17132

0.94

1.29

5.0

3.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

169

1.54

1.28

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

161

1.56

1.28

7.2

6.9

—

(3017732) Neutrophils [#/volume] in Blood

353

3172

1.12

1.27

2.9

3.2

e9/l

3.9

4.2

0.89

263

2407

(3034426) Prothrombin time (PT)

170

1.53

1.25

1.6

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

154

1.56

1.25

1.2

2.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

328

0.64

1.25

1.0

u/ml

0.9

0.3

—

(3045424) Erythrocytes [Presence] in Urine

788

1.23

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.91

1.22

1.8

1.5

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.63

1.21

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

227

0.57

1.21

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

109

1.65

1.18

3.9

2.1

mmol/l

7.8

8.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

332

1.36

1.18

1.8

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.00

1.16

1.0

1.3

nmol/l

0.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.50

1.15

1.2

1.8

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

236

2663

0.88

1.13

1.3

au/ml

22.2

57.4

—

120

(3035320) C reactive protein [Mass/volume] in Body fluid

318

1.35

1.12

4.9

2.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.12

1.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

119

1.60

1.11

1.3

—

(44806071)

1.96

1.11

1.1

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.38

1.09

1.2

1.5

mg/l

2.1

1.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.38

1.09

1.2

1.5

mg/l

0.7

1.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

605

0.76

1.09

1.1

u/ml

1.0

1.9

1.03

265

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.82

1.08

2.3

1.7

—

(3014891) Appearance of Pleural fluid

1.73

1.08

2.5

1.6

—

(40761535) Cells panel - Urine sediment

442

4060

1.10

1.08

4.2

3.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

128

1.56

1.08

2.8

2.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.19

1.08

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

903

0.81

1.06

1.5

1.8

iu/l

4.0

4.9

0.28

295

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

265

2954

0.89

1.06

2.4

au/ml

37.0

22.4

—

123

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

348

1.32

1.05

1.8

2.1

13.6

14.6

0.17

143

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.12

1.05

5.6

7.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

476

0.73

1.04

1.1

u/ml

0.1

2.1

—

115

(3008401) Mugwort IgE Ab [Units/volume] in Serum

521

0.75

1.04

1.1

u/ml

0.5

0.9

0.81

230

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

229

1.40

1.03

1.1

1.2

ratio

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

177

0.56

1.01

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.88

1.00

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.88

1.00

1.0

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

248

1.37

0.99

2.3

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

283

1.35

0.98

3.1

3.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.97

0.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

209

1857

1.13

0.97

1.7

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.80

0.96

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

157

1.47

0.95

2.1

2.4

nmol/l

151.4

141.5

0.13

141

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.69

0.95

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

205

2299

0.89

0.93

2.5

3.4

pmol/l

3.9

4.4

9.76

173

2028

(3023430) Cat dander IgE Ab [Units/volume] in Serum

363

0.71

0.93

1.1

u/ml

8.1

4.0

0.28

150

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

382

1.29

0.93

1.6

1.9

u/field

1.7

1.8

0.10

150

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

109

1.56

0.93

1.2

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.73

0.92

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

571

6092

0.93

0.91

14.3

7.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

171

0.58

0.91

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

171

0.58

0.91

1.3

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

218

1.38

0.91

2.8

2.3

umol/l

62.8

55.6

0.50

174

(3011985) Renin [Units/volume] in Plasma

627

1.21

0.90

1.3

1.4

mu/l

126.1

62.5

0.63

565

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

170

0.59

0.89

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

170

0.59

0.89

1.3

1.4

—

(3000034) Microalbumin [Mass/volume] in Urine

492

1.24

0.89

4.6

3.1

mg/l

95.0

66.2

0.35

369

(40768804) Tissue Pathology biopsy report

1876

18194

1.05

0.89

2.4

2.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

628

6665

0.94

0.87

1.3

1.2

u/ml

14.0

12.6

0.16

199

2484

(3015183) Erythrocyte sedimentation rate

180

0.61

0.86

1.3

1.2

—

(4015189)

153

1.44

0.85

1.6

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

187

1.39

0.84

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

104

1.54

0.84

1.0

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

248

1.33

0.83

7.9

10.5

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.74

0.82

2.4

2.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

571

1.21

0.81

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

532

0.79

0.80

1.0

1.1

u/ml

1.4

4.4

2.87

265

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

164

1.40

0.79

1.1

u/ml

7.0

3.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.73

0.79

1.2

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

707

0.82

0.79

1.4

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.82

0.79

2.8

3.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

148

0.61

0.78

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

395

0.76

0.77

1.1

u/ml

4.1

2.4

0.22

160

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.70

0.75

1.0

1.2

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.64

0.75

1.0

1.3

nmol/l

8.9

483644.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

1.45

0.75

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

569

0.81

0.73

1.1

—

9.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

133

1.43

0.73

1.2

1.3

g/l

0.3

0.13

103

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

108

1.48

0.73

1.3

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

672

7066

0.94

0.72

1.3

iu/ml

52.5

35.7

1.07

213

2173

(3038071) Oxygen [Partial pressure] in Mixed venous blood

142

1.41

0.72

7.3

7.0

—

(3000285) Sodium [Moles/volume] in Blood

1.62

0.71

1.4

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.58

0.71

1.1

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

327

1.26

0.70

1.5

nmol/l

0.3

0.2

0.25

244

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

554

0.81

0.70

1.2

mmol/l

9.9

7.6

2.71

410

(3005033) Fetal Nuchal fold Thickness US

144

0.62

0.69

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

193

0.67

0.69

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

145

0.62

0.69

1.3

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.68

1.6

1.2

u/l

6.7

12.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

120

0.58

0.67

1.4

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

475

1.20

0.66

1.4

1.5

20.6

27.8

1.03

298

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

111

1.44

0.65

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.59

0.65

1.1

3.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.57

0.65

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

137

1.39

0.64

1.1

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

260

1.27

0.63

7.5

5.8

u/ml

116.2

811.8

0.58

(3037556) Urate [Mass/volume] in Serum or Plasma

172

1.34

0.63

2.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

719

1.16

0.63

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.52

0.62

2.8

5.3

—

(3024869) Neuronal Ab [Presence] in Serum

104

1.44

0.62

1.0

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

553

1.18

0.62

1.4

1.3

nmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

140

1258

1.12

0.61

1.5

1.7

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.61

1.2

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

622

5934

1.05

0.61

4.6

4.7

31.8

32.0

0.18

489

4042

(4024509)

425

1.20

0.61

1.5

1.6

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

30.5

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.54

0.59

1.3

1.9

—

(3000330) Specific gravity of Urine by Test strip

263

2444

1.08

0.58

4.6

3.4

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

193

1.30

0.57

1.2

1.6

nmol/l

6.5

7.0

0.04

163

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

623

1.16

0.57

1.5

70.6

60.7

1.27

401

(40758292) HTLV I+II Ab panel - Serum

1.48

0.57

1.3

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.67

0.56

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.43

0.56

1.1

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

587

1.16

0.56

1.1

1.3

pmol/l

431.4

281.3

1.45

440

(40768795) Lymph node Pathology biopsy report

451

0.82

0.56

1.3

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

185

1.30

0.56

1.0

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.54

0.55

1.1

—

(3008898) HLA-B27 [Presence]

106

1186

0.89

0.55

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.58

0.54

2.0

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.54

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.62

0.52

1.0

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

227

2111

1.08

0.51

1.6

—

(4034850)

140

1531

0.91

0.49

15.7

9.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.56

0.49

1.4

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

172

1.28

0.48

1.0

1.1

90.9

96.6

0.22

141

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

247

2314

1.07

0.47

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

321

0.81

0.46

1.5

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.62

0.45

1.0

—

(3020650) Glucose [Presence] in Urine

118

0.68

0.45

1.6

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

103

1.36

0.45

2.1

2.7

u/l

593.4

1521.9

0.55

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

130

1.31

0.43

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1240

12109

1.03

0.42

5.0

4.0

estimate

0.0

0.19

457

3921

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.40

0.42

1.3

1.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.40

0.42

1.3

1.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.40

0.42

1.3

1.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.40

0.42

1.1

1.3

—

577.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

542

0.87

0.42

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

542

0.87

0.42

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

632

1.12

0.42

1.4

1.3

nmol/l

0.2

0.3

1.21

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3024263) Appearance of Synovial fluid

286

1.19

0.41

1.5

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

6.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

7.9

—

(3013862) HLA-DP [Type]

0.00

0.40

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.40

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.40

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.40

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.40

0.0

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

292

2770

1.06

0.40

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

701

1.11

0.40

2.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.43

0.39

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.39

0.0

1.5

—

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1053

0.91

0.39

4.1

3.5

mg/l

34.5

28.9

0.64

661

(40768793) Breast Pathology biopsy report

675

0.89

0.38

1.4

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.26

0.36

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.29

0.36

1.2

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

878

1.09

0.36

2.0

—

(4211845)

232

0.82

0.33

3.8

3.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

538

0.89

0.31

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

165

1.21

0.31

1.7

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

240

0.83

0.30

1.1

1.2

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

1.31

0.30

1.1

u/ml

1.9

2.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1023

0.93

0.28

1.1

—

(3049717) Cytology report of Urine Cyto stain

217

2275

0.95

0.28

2.6

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

970

0.93

0.28

1.5

1.7

mu/l

338.6

293.6

0.83

905

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.29

0.28

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

453

1.10

0.25

1.1

—

19.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

330

1.12

0.25

1.8

2.0

nmol/l

16.4

17.3

0.10

311

(44813793)

255

0.86

0.24

1.1

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

189

1.16

0.24

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

124

1.21

0.24

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

143

1.19

0.23

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

106

1.23

0.23

2.7

2.4

—

(3006462) Nitrate [Presence] in Urine

211

0.85

0.23

3.4

3.3

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.22

0.22

1.6

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

178

0.84

0.22

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

135

0.81

0.22

1.4

1.3

9.8

30.5

—

(3014051) Protein [Presence] in Urine by Test strip

101

1070

0.94

0.21

2.4

2.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

296

1.12

0.21

1.1

mg/l

278.4

315.0

0.87

255

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.16

0.21

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.3

—

2.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

117

1.20

0.20

6.4

7.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

0.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

240

1.13

0.20

1.0

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

108

1.20

0.20

1.3

1.2

—

626.7

—

(3022621) pH of Urine by Test strip

311

3021

1.03

0.19

3.2

2.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

133

0.83

0.19

1.0

1.1

—

(3045414) Leukocytes [Presence] in Urine

215

2077

1.04

0.19

1.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

318

1.10

0.18

1.2

1.1

titre

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

280

1.11

0.18

1.4

1.3

u/ml

2.8

1.9

0.20

140

(3019150) Specific gravity of Urine by Refractometry

966

9794

0.98

0.18

5.1

4.0

kg/l

1.0

2.93

180

1442

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

216

2231

0.97

0.17

1.1

1.2

iu/ml

103.0

134.5

0.55

791

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

174

0.86

0.17

1.1

1.2

—

(3025130) Human papilloma virus identified in Specimen

252

1.11

0.17

2.1

1.8

—

(4027681)

224

1.12

0.17

1.4

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

547

0.93

0.17

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

476

1.07

0.16

1.1

—

11.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

204

0.88

0.16

1.3

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.20

0.16

1.2

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.11

0.16

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

283

1.10

0.15

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

121

1.16

0.15

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

121

1.16

0.15

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

121

1.16

0.15

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

121

1.16

0.15

1.1

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

160

0.87

0.14

1.0

1.1

u/ml

0.7

2.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.81

0.13

1.6

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1168

11792

0.99

0.13

4.4

3.3

—

(3022689) Creatine [Moles/volume] in Urine

151

1.13

0.13

2.4

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

138

0.87

0.13

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

403

1.07

0.13

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

256

2504

1.02

0.12

1.3

u/ml

516.2

263.9

1.13

241

2305

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

181

1.11

0.12

2.5

2.8

umol/l

32.8

29.1

0.29

130

(1617658) Protocol used for examination of sentinel lymph nodes

230

0.91

0.11

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

309

1.07

0.10

1.2

mg/l

45.5

45.4

0.01

259

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

731

1.04

0.10

1.9

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.15

0.09

1.2

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

248

0.93

0.09

14.5

13.5

nmol/l

775.2

828.0

0.27

234

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

487

1.05

0.09

1.1

u/ml

2.4

2.8

0.18

214

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.09

0.08

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.07

0.08

1.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

206

0.92

0.08

1.3

1.5

ug/l

13.0

9.0

0.64

181

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.81

0.08

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

102

1047

0.97

0.08

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.83

0.07

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

201

0.95

0.04

1.1

ng/l

46.8

440.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

965

0.98

0.03

1.4

iu/l

29.2

30.3

0.12

813

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

114

1125

1.01

0.03

1.4

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

218

0.96

0.02

1.0

1.1

u/l

1.0

1.1

—

117

(3034891) Synovial lining cells/100 cells in Synovial fluid

244

1.02

0.00

1.4

1.5

2.6

4.3

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

135

1.04

0.00

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

195

1.03

0.00

1.6

2.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

133

0.98

0.00

1.0

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

193

0.98

0.00

1.8

2.0

ug/l

15.4

61.7

0.62

177

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

253

0.99

0.00

20.5

18.4

nmol/l

1493.5

1413.6

0.25

246

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.4

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.1

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.9

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

0.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.91

0.00

2.0

1.6

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

0.90

0.00

1.7

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

137.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.88

0.00

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1577.1

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.00

0.00

1.6

1.1

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.0

1.0

—

169.4

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.02

0.00

3.0

2.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.92

0.00

1.6

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

8.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.93

0.00

1.4

1.5

umol/l

32.4

44.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.98

0.00

14.4

6.5

—

Mortality – FinRegistry

↥

Association

Association between endpoint CIRRHOSIS_BROAD and mortality.

Females

Parameter	HR [95% CI]	p-value
CIRRHOSIS_BROAD	8.13 [7.25, 9.12]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.037

During the follow-up period (1.1.1998 — 31.12.2019), 6151 out of 11927 females with CIRRHOSIS_BROAD died.

Males

Parameter	HR [95% CI]	p-value
CIRRHOSIS_BROAD	8.378 [7.44, 9.44]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 14589 out of 24815 males with CIRRHOSIS_BROAD died.

Mortality risk

Mortality risk for people of age

years, who have CIRRHOSIS_BROAD.

N-year risk	Females	Males
1	0.801%	1.206%
5	4.445%	8.315%
10	9.334%	19.603%
15	17.842%	34.865%
20	30.193%	53.154%

Relationships between endpoints

↥

Index endpoint: CIRRHOSIS_BROAD – Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints